Missing data in multi-omics integration: Recent advances through artificial intelligence
Open accessAbstract
Biological systems function through complex interactions between various ‘omics (biomolecules), and a more complete understanding of these systems is only possible through an integrated, multi-omic perspective. This has presented the need for the development of integration approaches that are able to capture the complex, often non-linear, interactions that define these biological systems and are adapted to the challenges of combining the heterogenous data across ‘omic views. A principal challenge to multi-omic integration is missing data because all biomolecules are not measured in all samples. Due to either cost, instrument sensitivity, or other experimental factors, data for a biological sample may be missing for one or more ‘omic techologies. Recent methodological developments in artificial intelligence and statistical learning have greatly facilitated the analyses of multi-omics data, however many of these techniques assume access to completely observed data. A subset of these methods incorporate mechanisms for handling partially observed samples, and these methods are the focus of this review. We describe recently developed approaches, noting their primary use cases and highlighting each method's approach to handling missing data. We additionally provide an overview of the more traditional missing data workflows and their limitations; and we discuss potential avenues for further developments as well as how the missing data issue and its current solutions may generalize beyond the multi-omics context.
AI snapshot
Written from the paper’s full text.
TL;DR
This review surveys recent AI/ML multi-omics integration methods that explicitly handle partially observed data, either by joint imputation within the model or by optimization masking of missing components. It also summarizes traditional missing-data workflows and discusses limitations, especially sample-size demands, limited coverage of mass-spectrometry omics, and interpretability.
Key findings
- Missing data are pervasive in omics: proteomics can have 20–50% of possible peptide values unquantified, and the human proteome project estimates ~20% of genes yield protein products not detected by mass spectrometry.
- The review groups missing-data-robust integration methods into joint-imputation approaches (e.g., FBM, iMODA, MOFA/MOFA+, BIDIFAC+) and optimization-masking approaches (e.g., TiMEG, COMBI, MVAE, DeepMF, MvNE, DeepIMV, JACA, SUMO, NEMO, MSNE, MONET), across early, middle, and late integration categories.
- Reported performance varies with missingness: FBM prediction RMSE increased with missing percentage, most prominently when both gene expression and methylation had 30% missingness; iMODA power decreased with 50% and 30% missingness; MOFA imputation had lower MSE than feature-wise mean, SoftImpute, and KNN across ~10–80% missingness; DeepMF identified simulated MCAR sample/feature subgroups with perfect accuracy at 10%, 50%, and 70% missingness; SUMO slightly outperformed NEMO except at extreme missingness (80% and greater).
- BIDIFAC+ enables bi-dimensional integration across omics and sample cohorts, but took nearly 24 h to converge on a combined TCGA dataset, and assumes shared structures are present across integrated matrices.
Methods
- Narrative review of AI/ML and statistical-learning approaches for multi-omics integration that accommodate missing data, plus background on traditional missing-data mechanisms (MCAR, MAR, MNAR) and imputation/complete-case workflows.
- Methods are categorized by integration strategy (early/concatenation, middle/transformation-based, late/model-based) and by missing-data handling strategy (joint-imputation vs. optimization-masking).
- Table 1 summarizes each reviewed method’s integration approach, missing-data approach, compatible omics platforms, primary use case, application dataset characteristics, and software availability.
Limitations
- The paper states that many reviewed methods implicitly require relatively large sample sizes, as their application datasets contain hundreds to thousands of observations, which may be prohibitive for rare diseases or small studies.
- The paper states that many methods were motivated by or evaluated on sequencing-based omics, with few considering metabolomics, proteomics, or lipidomics, where mass-spectrometry-specific batch effects, missingness mechanisms, and identification uncertainty may violate model assumptions.
- The paper notes that only FBM and iMODA describe how correlation structure is modeled or affects results among joint-imputation approaches, and that many middle-integration methods are black-box with limited interpretability; evident from the text, this is a review rather than an independent benchmark, so performance claims are drawn from original publications and simulations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 80 cited sources checked · 0 supported · 0 flagged
- Findingnone given
Few of the multi-omics integration methods reviewed explicitly require the use of multi-omics data.
“While all these methods have been presented within the context of multi-omics integration, few explicitly require the use multi-omics data.”
Quote in the paperNot a substantial claim - Findingreasoning
Many of the middle integration methods discussed in this review are black-box in nature, as the specific relationships learned by each are often incommunicable.
“many of the middle integration methods discussed here are black-box in nature, as the specific relationships learned by each are often incommunicable.”
Quote in the paperSubstantial claim - Premisecitation
Data integration is one of the primary barriers to effective multi-omics research and reaching the desired holistic view of the biological system being studied.
“However, data integration is one of the primary barriers to effective multi-omics research and reaching the desired holistic view of the biological system being studied (Misra et al., 2019).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Misra et al., 2019 source
Not checked in the free run.
- Premisenone given
Many recent artificial intelligence and statistical learning techniques for multi-omics data assume access to completely observed data.
“Recent methodological developments in artificial intelligence and statistical learning have greatly facilitated the analyses of multi-omics data, however many of these techniques assume access to completely observed data.”
Quote in the paperSubstantial claim - Premisereasoning
A subset of artificial intelligence and statistical learning methods for multi-omics incorporate mechanisms for handling partially observed samples.
“A subset of these methods incorporate mechanisms for handling partially observed samples, and these methods are the focus of this review.”
Quote in the paperSubstantial claim
- Premisecitation
Machine learning and artificial intelligence have shown promise in overcoming some hindrances to multi-omics integration.
“Machine learning (ML) and artificial intelligence (AI) have shown promise in overcoming some of these hindrances (e.g., Mirza et al., 2019; Zhu, 2020) and have gained popularity in recent years.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
FBM's decreases in predictive performance with missingness are mitigated as sample size increases.
“However, the observed decreases in predictive performance were observed to be mitigated as the sample size was increased.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fang et al., 2018 source
Not checked in the free run.
- The authors state this as an assumption: The FBM model assumes gene-gene and methylation-methylation independence, and imputed values reflect this assumption.
- Premisecitation
The human proteome project reports that an estimated ~20% of genes yield protein products that are not detected by mass spectrometry.
“For example, the human proteome project reports that an estimated ~20% of genes yield protein products that are not detected by mass spectrometry, an analytic platform for protein quantification (Paik et al., 2012; Baker et al., 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
For BIDIFAC, a similar trend of smallest imputation error for stronger signal is observed for block-level missingness.
“A similar trend is observed for block-level missingness, which is the type of missingness where several omics (columns) are missing across a set of samples (rows).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lock et al., 2022 source
Not checked in the free run.
- Premisecitation
It is not uncommon to have 20-50% of the possible peptide values that are not quantified.
“It is not uncommon to have 20–50% of the possible peptide values that are not quantified (Webb-Robertson et al., 2015; Brenes et al., 2019).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
TiMEG's power decreases as the percentage of missing data increases.
“As the percentage of missing data increases, the power decreases.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Das and Mukhopadhyay (2021)
Not checked in the free run.
- Rests on an assumption: Gene expression is known to be affected by changes to the DNA sequence.
- Premisecitation
For BIDIFAC, for column-missingness, imputation error is smallest for stronger joint-signal strength.
“For column-missingness, where entries for an entire ‘omic are missing across all samples, imputation error is smallest for stronger joint-signal strength.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lock et al., 2022 source
Not checked in the free run.
- Premisenone given
COMBI's quasi-likelihood estimation approach is robust to missing data values.
“The quasi-likelihood estimation approach is also robust to missing data values.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
Discarding data is typically not the preferable option for multi-omics data analysis, due to data types with high amounts of missing data or complex mechanisms behind missing observations.
“Discarding data is typically not the preferable option for multi-omics data analysis, due to data types with high amounts of missing data or complex mechanisms behind missing observations.”
Quote in the paperSubstantial claim - Premisecitation
FBM simulation studies showed that prediction root mean squared error increases as missing data percentage increases.
“Simulation studies performed in the original publication indicate increases in the root mean squared error of prediction with increases in missing data percentage.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fang et al., 2018 source
Not checked in the free run.
- The authors state this as an assumption: The FBM model assumes gene-gene and methylation-methylation independence, and imputed values reflect this assumption.
- Premisecitation
Missing values in large-scale 'omics data can hinder downstream analyses.
“It has been shown that missing values in large-scale ‘omics data can hinder downstream analyses (Ouyang et al., 2004; Jörnsten et al., 2005).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
For BIDIFAC, simulation studies indicate that for entry-level missingness, imputation error is smallest for stronger signals.
“Simulation studies assessing the performance of BIDIFAC across different types of missingness (entry, column, and block) and signal strength indicate that for entry-level missingness, imputation error is smallest when for stronger signals.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lock et al., 2022 source
Not checked in the free run.
- Interpretationreasoning
For data integration, missing data is especially challenging because the set of observations with missing data and the proportion of missingness can vary among the different 'omics datasets.
“For data integration, missing data is especially challenging because the set of observations with missing data and the proportion of missingness can vary among the different ‘omics datasets.”
Quote in the paperSubstantial claim - Premisecitation
In a simulated setting, MOFA imputation resulted in lower mean squared error of prediction than feature-wise mean, SoftImpute, and k-nearest neighbor across varying percentages of missingness.
“Comparing these approaches in a simulated setting, it was found that imputation by MOFA resulted in a lower mean squared error of prediction (i.e., imputation) relative to compared methods across varying percentages of missingness.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
TiMEG controls the type 1 error rate at the nominal rate across changes in missing data percentages.
“However, across changes in missing data percentages, the type 1 error rate is controlled at the nominal rate.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Das and Mukhopadhyay (2021)
Not checked in the free run.
- Rests on an assumption: Gene expression is known to be affected by changes to the DNA sequence.
- Interpretationnone given
A separate imputation procedure-particularly those that are more computationally sophisticated-is suboptimal from an efficiency standpoint.
“A separate imputation procedure—particularly those that are more computationally sophisticated—is also suboptimal from an efficiency standpoint.”
Quote in the paperNot a substantial claim - Premisenone given
A majority of artificial intelligence and machine learning methods require complete data with no missing observations.
“One limitation of AI and ML models is that a majority of methods require complete data with no missing observations, requiring a user to discard data for any biomolecule with a missing value, remove samples with any missing values, or impute missing values, either before input into the model or implicitly done by the model's software implementation, or some combination of these options.”
Quote in the paperSubstantial claim - Premisecitation
The increase in FBM prediction root mean squared error with missingness is most prominent when both gene expression and methylation data have high missingness (30%).
“This effect was observed to be most prominent when both gene expression and methylation data were characterized by high percentages of missingness (i.e., 30%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fang et al., 2018 source
Not checked in the free run.
- The authors state this as an assumption: The FBM model assumes gene-gene and methylation-methylation independence, and imputed values reflect this assumption.
- Interpretationnone given
The vast majority of these integration approaches require completely observed data for their implementation.
“The vast majority of these integration approaches require completely observed data for their implementation.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Variations in sample handling, temperature fluctuation, imprecise timing, LC/GC column degradation and other factors result in systematic errors or biases of measured abundances between batches or over time.
“Variations in sample handling, temperature fluctuation, imprecise timing, liquid chromatography/gas chromatography (LC/GC) column degradation and other factors result in systematic errors or biases of the measured abundances between the batches or over time.”
Quote in the paperNot a substantial claim - Premisecitation
Other transcriptomics platforms require at least 35 samples per group to detect the same magnitude fold change at the same power and false discovery rate levels.
“This is as opposed to other (larger) transcriptomics platforms that would require at least 35 samples per group to detect the same magnitude fold change at the same power and false discovery rate levels (Krassowski et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Krassowski et al., 2020 source
Not checked in the free run.
- Premisecitation
NEMO can handle partially observed samples provided that these samples are observed in at least one view common to other observed samples.
“NEMO can handle partially observed samples, provided that these samples are observed in at least one view common to other observed samples.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rappoport and Shamir, 2019 source
Not checked in the free run.
- Premisecitation
Batch effects are common and often much more pronounced in mass spectrometry-based data, even when the same physical instrument is used and the same data type is being generated.
“For example, batch effects are common and often much more pronounced in mass spectrometry-based data (Mertens, 2016; Phua et al., 2022; e.g., Han and Li, 2020), even when the same physical instrument is used and the same data type is being generated.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
SUMO slightly outperformed NEMO in robustness to varying levels of missing samples, except at extreme missingness of 80% and greater.
“These comparisons indicated a slight outperformance by SUMO, except for in the cases of extreme missingness (80% and greater).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
Approaches that naïvely combine data views may inadvertently overrepresent relationships particular to a high SNR omics and underrepresent lower SNR omics.
“Thus, approaches that naïvely combine these data views may inadvertently overrepresent relationships particular to a high SNR ‘omics and underrepresent lower SNR ‘omics.”
Quote in the paperSubstantial claim - Premisereasoning
Mass spectrometry-based data types differ from sequence-based omics data types.
“given the differences in mass spectrometry-based data types compared to sequence-based omics data types.”
Quote in the paperSubstantial claim - Premisecitation
Additional sources of uncertainty may arise from processes such as protein quantification in bottom-up proteomics because measurements are made at the peptide level and isoforms can be difficult to identify.
“additional sources of uncertainty may arise from processes such as protein quantification in bottom-up proteomics (Rifai et al., 2006; Plubell et al., 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al., 2011; Webb-Robertson et al., 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Provided that data are missing completely at random (MCAR) or missing at random (MAR), COMBI's quasi-likelihood estimation procedure yields unbiased parameter estimates based on all complete or partial observations.
“Provided that the data are missing completely at random (MCAR) or missing at random (MAR), the quasi-likelihood estimation procedure yields unbiased parameter estimates based on all (complete or partial) observations.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Heterogeneity across omics may also be observed in terms of missing data patterns or confounders, especially because different omics are collected on different instrumentation that vary in accuracy, precision, and detection ability.
“Beyond variability and signal strength, heterogeneity across ‘omics may also be observed in terms of their missing data patterns or confounders, especially considering that different ‘omics are collected on different instrumentation that vary in their accuracy, precision, and detection ability.”
Quote in the paperNot a substantial claim - Interpretationnone given
Of the joint-imputation approaches discussed in the review, only FBM and iMODA describe ways in which the correlation structure is modeled or impacts results.
“Of the joint-imputation approaches discussed in this review, only the FBM and iMODA approaches describe ways in which the correlation structure is modeled or impacts results.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The FBM model assumes gene-gene and methylation-methylation independence, and imputed values reflect this assumption.
- Interpretationreasoning
Maximizing MONET's objective function for heavy subgraph detection is an NP-hard problem.
“As a result, maximizing the objective function for heavy subgraph detection is an NP-hard problem.”
Quote in the paperSubstantial claim - Premisecitation
Other studies involving rare diseases, difficult-to-access tissue, or smaller grants are characterized by similarly low sample sizes.
“Other studies that involve rare diseases, the collection of difficult-to-access tissue, or smaller grants that do not allow for large consortium samples are characterized by similarly low sample sizes (Sirrs et al., 2015; Abela et al., 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In evaluating DeepMF at 10%, 50%, and 70% missingness, Chen et al. found that DeepMF was consistently able to identify sample and feature subgroups with perfect accuracy.
“In evaluating the robustness of DeepMF to varying levels of missingness (10, 50, and 70%), Chen et al. (2019) found that DeepMF was consistently able to identify sample and feature subgroups with perfect accuracy.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 2019 source
Not checked in the free run.
- Interpretationreasoning
The ability to capture dependencies and correlations across omics data types is important because known biological relationships exist between these data.
“Though the shared structure assumption made by BIDIFAC+ may pose as problematic in certain practical instances, the ability to capture dependencies and correlations across ‘omics data types is important when considering that known biological relationships exist between these data.”
Quote in the paperSubstantial claim - Interpretationreasoning
For joint-imputation approaches, capturing data dependencies is particularly important because imputed values may otherwise be biased, affecting downstream results.
“For joint-imputation approaches, which “predict” missing values, capturing data dependencies is particularly important as imputed values may be otherwise biased, affecting downstream results.”
Quote in the paperSubstantial claim - Interpretationreasoning
A limitation common to several reviewed approaches is an implicit requirement of relatively larger sample sizes for model estimation or fitting.
“A limitation common to several approaches, for example, is the implicit requirement of relatively larger sample sizes for model estimation or fitting.”
Quote in the paperSubstantial claim - Interpretationreasoning
Mechanisms for missing data can be more complex in mass spectrometry data, as described for proteomics data previously in the paper.
“Further, mechanisms for missing data can be more complex in the case of mass spectrometry data, as described for proteomics data previously in this paper.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The need for manual verification in shotgun metabolomics can result in increased misidentifications and missing values compared with omics data types that have more established identification algorithms, such as transcriptomics and genomics.
“This can result in increased misidentifications and missing values compared to ‘omics data with more established identification algorithms such as transcriptomics and genomics.”
Quote in the paperSubstantial claim - Premisecitation
Relying on over-parametrized models such as DNNs to learn non-spurious, inspectable relationships is not a reliable strategy.
“relying on over-parametrized models such as DNN's to learn non-spurious, inspectable relationships is not a reliable strategy (Lee and Kim, 2022).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee and Kim, 2022
Not checked in the free run.
- Premisecitation
Efforts to combine biological-knowledge-injecting methods such as graph representations or other hard constraints on parameter representations with machine learning methods are ongoing.
“efforts to combine biological-knowledge-injecting methods such as graph representations or other hard constraints on parameter representations with machine learning methods are ongoing (Noor et al., 2019; Lee and Kim, 2022)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Noor et al., 2019 source
Not checked in the free run.
- cites Lee and Kim, 2022
Not checked in the free run.
- Interpretationcitation
Biologically informed constraints are likely critical to develop successful approaches.
“These biologically informed constraints are likely critical to develop successful approaches, as relying on over-parametrized models such as DNN's to learn non-spurious, inspectable relationships is not a reliable strategy (Lee and Kim, 2022).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee and Kim, 2022
Not checked in the free run.
- May combine two claims. 41
- Classified as probably not a substantial claim. 30
May combine two claims.
FindingreasoningIdentifying these groupings within latent factors is often a post-hoc process, and such domain-relevant groupings are not always identifiable within generated latent factors.
“Identifying these groupings within latent factors is often a post-hoc process, however, and such domain-relevant groupings are not always identifiable within generated latent factors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningA principal challenge to multi-omic integration is missing data because all biomolecules are not measured in all samples.
“A principal challenge to multi-omic integration is missing data because all biomolecules are not measured in all samples.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenHinderances to effective integration methods include the heterogeneous nature of data and distributional properties across multi-omics datasets, the typically large difference in the number of measured biomolecules compared to number of samples or replicates, and the complex and often noisy nature of biological data.
“Hinderances to effective integration methods include, but are not limited to, the heterogeneous nature of data and distributional properties across multi-omics datasets, the typically large difference in the number of measured biomolecules compared to number of samples or replicates, and the complex and often noisy nature of biological data.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Premisenone givenData for a biological sample may be missing for one or more 'omic technologies due to cost, instrument sensitivity, or other experimental factors.
“Due to either cost, instrument sensitivity, or other experimental factors, data for a biological sample may be missing for one or more ‘omic techologies.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAdditional complexities including protein isolation and solubilization, sequence ambiguity, and a lack of standards in statistical thresholds and algorithms result in inconsistent detection of large proportions of protein products that are detected, thus limiting the reproducibility of data collection and analysis.
“Furthermore, additional complexities including protein isolation and solubilization, sequence ambiguity, and a lack of standards in statistical thresholds and algorithms result in inconsistent detection of large proportions of protein products that are detected, thus limiting the reproducibility of data collection and analysis (Goh and Wong, 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Goh and Wong, 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
InterpretationreasoningIn 'omics studies, data are more commonly MNAR or MAR, considering that instruments are known to have certain detection thresholds (MNAR) and that biochemical dependencies exist between different biomolecules (MAR).
“In ‘omics studies, data are more commonly MNAR or MAR, considering that instruments are known to have certain detection thresholds (MNAR) and that biochemical dependencies exist between different biomolecules (MAR).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenIf an entire view is missing for one or more samples and must be imputed, any level of similarity specific to that view may be lost.
“If an entire view is missing for one or more samples and must be imputed, any level of similarity specific to that view may be lost.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenMissing data are common in 'omics data and can arise due to a variety of reasons, such as poor tissue quality, insufficient sample volume, measurement system limitations, budget restrictions, or subject dropout.
“Missing data are common in ‘omics data and can arise due to a variety of reasons, such as poor tissue quality, insufficient sample volume, measurement system limitations, budget restrictions, or subject dropout.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningWhen faced with missing data, these integration methods require a complete case analysis or the implementation of separate imputation steps beforehand.
“When faced with missing data, these methods thus require a complete case analysis or the implementation of separate imputation steps beforehand.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationModels incorporating gene-gene and methylation-methylation correlations were considered for FBM but had higher computational cost without substantive performance gains relative to independence models.
“However the authors note that models incorporating gene-gene and methylation-methylation correlations were additionally considered, but these models were associated with a higher computational cost without indicating substantive gains in performance relative to models based on the independence assumption.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fang et al., 2018 source
Not checked in the free run.
- The authors state this as an assumption: The FBM model assumes gene-gene and methylation-methylation independence, and imputed values reflect this assumption.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningGiven the prevalence of missing data across different 'omics, the approach that machine learning and artificial intelligence models use in handling missing observations is of great importance when considering multi-omics integration methods.
“Given the prevalence of missing data across different ‘omics, the approach that ML and AI models use in handling missing observations is of great importance when considering multi-omics integration methods.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationKNN imputation has been shown to work well for numerical imputation on single datasets, but the algorithm is sensitive to the choice of the number of nearest neighbors (k) and is limited in that it does not utilize the potential structure across the entire set of observations.
“KNN imputation has been shown to work well for numerical imputation on single datasets (Jadhav et al., 2019), but the algorithm is sensitive to the choice of the number of nearest neighbors (k) and is limited in that it does not utilize the potential structure across the entire set of observations.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jadhav et al., 2019 source
Not checked in the free run.
May combine two claims.
PremisereasoningAvailable case analysis, while more robust than complete case analysis since less data are dropped, is still only valid under the MCAR assumption and generates conclusions based on different parts of the data, potentially leading to biased or conflicting inference.
“While more robust than a complete case analysis since less data are dropped, an available case analysis is still only valid under the MCAR assumption and generates conclusions based on different parts of the data, potentially leading to biased or conflicting inference.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationZero-value or LOD imputation, like mean imputation, may distort feature distributions and lead to biased parameter and variability estimates.
“However, like mean imputation, imputed values from these approaches may distort feature distributions and lead to biased parameter and variability estimates (Lubin et al., 2004; Succop et al., 2004; Webb-Robertson et al., 2015; Lazar et al., 2016; Bramer et al., 2020).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMiddle integration applies some transformation to represent a complex combination of the datasets before applying downstream analyses.
“Middle integration applies some transformation to represent a complex combination of the datasets before applying downstream analyses.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ritchie et al., 2015 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMissing samples in multi-omics data are rarely MCAR, and thus inference based on a complete case analysis is likely to be biased.
“Missing samples in multi-omics data are rarely MCAR, and thus inference based on a complete case analysis is likely to be biased.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningBoth the Xie et al. (2019) and Xu et al. (2019) methods require complete input, and initial imputation is performed in both cases to accommodate.
“Both these methods require complete input, and initial imputation is performed in both cases to accommodate.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Xie et al., 2019 source
Not checked in the free run.
- cites Xu et al., 2019
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
InterpretationreasoningKernel-based methods rely on an imputation pre-processing step, which could possibly negatively affect the downstream analyses, as the relationships between nodes/samples/biomarkers may be biased toward similarities in imputation.
“These methods rely on an imputation pre-processing step, which could possibly negatively affect the downstream analyses, as the relationships between nodes/samples/biomarkers may be biased toward similarities in imputation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenIntegration techniques generally assume measurements from the same samples on several markers, or features, from several 'omics-data types, which are more generally referred to as data views.
“Integration techniques generally assume measurements from the same samples on several markers, or features, from several ‘omics-data types, which are more generally referred to as data “views”.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMean imputation preserves feature means and grants access to the use of more data, but does not preserve relationships among variables and may lead to an underestimate of variability.
“While this simple approach preserves feature means and grants access to the use of more data, it does not preserve relationships among variables and may lead to an underestimate of variability (Gelman and Hill, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gelman and Hill, 2006 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenIn metabolomics, limited coverage of the known metabolome increases the risk of overlooking the metabolomic response of interest in targeted metabolomic analyses.
“In metabolomics, limited coverage of the known metabolome increases the risk of overlooking the metabolomic response of interest in targeted metabolomic analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEarly integration is primarily characterized by an initial concatenation of the features across all measured 'omics, followed by application of methods appropriate for analyzing the resulting high-dimensional dataset.
“Early integration is primarily characterized by an initial concatenation of the features across all measured ‘omics, followed by application of methods appropriate for analyzing the resulting high-dimensional dataset.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ritchie et al., 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationLate integration analyzes each dataset separately and introduces a model or algorithm that combines the outputs of each individual analysis.
“Late integration analyzes each dataset separately and introduces a model or algorithm that combines the outputs of each individual analysis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ritchie et al., 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationPeptides may be missing from one or more samples due to a variety of underlying mechanisms, which can result in non-trivial amounts of potential observations being missing.
“Peptides may be missing from one or more samples due to a variety of underlying mechanisms (Daly et al., 2008; Karpievitch et al., 2009), which can result in non-trivial amounts of potential observations being missing.”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningGiven the ubiquity of partially observed cases in multi-omics datasets-and that most integrative multi-omics methods are not inherently compatible with partially observed data-imputation methods are often incorporated as a data pre-processing step within the multi-omics analytic pipeline, or alternatively, partially observed samples are dropped and a complete case analysis is performed.
“Given the ubiquity of partially observed cases in multi-omics datasets—and that most integrative multi-omics methods are not inherently compatible with partially observed data—imputation methods are often incorporated as a data pre-processing step within the multi-omics analytic pipeline, or alternatively, partially observed samples are dropped and a complete case analysis is performed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningGiven the tendency of neural networks to overfit to the training data, it is possible that any bias in the imputation of the training data-which is likely due to the common violation of MAR in 'omics data-will be erroneously exploited by the network.
“Given the tendency of neural networks to overfit to the training data, it is possible that any bias in the imputation of the training data—which is likely due to the common violation of MAR in ‘omics data—will be erroneously exploited by the network.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the MOFA comparison, missing percentages ranged between approximately 10% and 80%, and all methods showed increased mean squared error of prediction with increased missing percentage.
“The missing percentages considered ranged between ~10–~80%, and all methods demonstrated increases to mean squared error of prediction with increased missing percentage.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Argelaguet et al., 2018 source
Not checked in the free run.
May combine two claims.
PremisecitationComplete case analysis, while convenient, results in a decrease in sample size, throws away useful data, is only valid under the MCAR assumption and can otherwise lead to biased estimates.
“This approach, while convenient, results in a decrease in sample size, throws away useful data, is only valid under the MCAR assumption and can otherwise lead to biased estimates (Fang et al., 2018; Hawinkel et al., 2020).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningMulti-omics data are uniquely characterized by several separate, yet related, datasets, which has motivated the development of newer approaches that leverage information across different 'omics datasets to inform imputations.
“Each of the previously described imputation methods have generally been developed within the context of a single dataset, however multi-omics data are uniquely characterized by several separate, yet related, datasets. This aspect of multi-omics has therefore motivated the development of several newer approaches that leverage information across different ‘omics datasets to inform imputations.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationiMODA's power to detect effects of interest varies with the proportion of missing data, and power decreases as missingness increases.
“The power of the iMODA framework to detect the effects of interest has been reported to vary according to the proportion of data that are missing. The authors considered cases where 50% and 30% of data were missing, finding that power decreases with increased missingness.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lin et al., 2020 source
Not checked in the free run.
- Rests on an assumption: The known causal hierarchy across biomolecules is that genotype affects omic expression, which influences phenotype.
May combine two claims.
InterpretationreasoningMany methods described were motivated by or evaluated exclusively on sequencing-based omics platforms, and few considered the fuller breadth of omics platforms including metabolomics, proteomics, and lipidomics.
“Related to this point, many of the methods described here were motivated by or evaluated exclusively on sequencing-based omics platforms (e.g., transcriptomics, genomics, and epigenomics) and few considered the fuller breadth of omics platforms that includes metabolomics, proteomics, lipidomics, etc.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningData of non-sequencing omics are typically generated by a mass spectrometer, an instrument whose use introduces several nuances to the data which may mean integration model assumptions reasonably made for sequencing-based data may not hold for mass spectrometry-based data.
“Contrasting with the sequencing-based ‘omics used by many of the methods reviewed in this work, data of other ‘omics are typically generated by a mass spectrometer, an instrument whose use introduces several nuances to the data which may mean integration model assumptions reasonably made for sequencing-based data may not hold for mass spectrometry-based data.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe datasets considered by these approaches contain hundreds, if not thousands, of observations, sample sizes that may be practically prohibitive due to cost, biospecimen availability, or both.
“The datasets considered by these approaches contain hundreds, if not thousands, of observations, sample sizes that may be practically prohibitive due to cost, biospecimen availability, or both.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMONET has no constraint on the number of detected modules and no upper bound on module size.
“Notably, there is no constraint on the number of detected modules, nor is there an upper bound on module size.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rappoport et al., 2020 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationBIDIFAC+ assumes that shared structures are present across the integrated matrices, an assumption that may be violated in practice.
“However, Lock et al. (2022) note that BIDIFAC+ assumes that shared structures are present across the integrated matrices, an assumption that may be violated in practice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lock et al., 2022 source
Not checked in the free run.
- The authors state this as an assumption: BIDIFAC+ assumes that shared structures are present across the integrated matrices.
May combine two claims.
PremisecitationMVAE's product-of-experts model architecture is robust to partially observed samples, combining only the omic-specific encodings of each partial sample's observed omics during model training.
“This PoE model architecture is robust to partially observed samples, combining only the ‘omic-specific encodings of each partial sample's observed ‘omics during model training.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu and Goodman (2018)
Not checked in the free run.
- The authors state this as an assumption: MVAE assumes that data views are independent from one another, given a shared latent representation.
May combine two claims.
Premiseown dataSUMO's range of adjusted rand index values was typically narrower than NEMO's, suggesting less variability in expected performance.
“As well, the range of adjusted rand index values (the performance metric used) was typically observed to be narrower for SUMO, suggesting less variability in expected performance.”
Quote in the paperNot a substantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisereasoningMONET's authors propose a heuristic algorithm that identifies a local maximum and recommend using the best solution from repeated runs to better approximate the globally maximal solution.
“The authors circumvent this issue by proposing a heuristic algorithm that identifies a local maximum and recommend using the best solution from repeated runs of the algorithm to better approximate the globally maximal solution.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rappoport et al., 2020 source
Not checked in the free run.
May combine two claims.
Study design and conductcitationDeepMF's perfect-accuracy evaluations were completed in a simulated data setting in which data were simulated as missing completely at random (MCAR) and ground truth feature subgroups were generated with simple discrimination boundaries.
“However, it should be noted that these evaluations were completed in a simulated data setting in which data were simulated as missing completely at random (MCAR) and ground truth feature subgroups were generated with simple discrimination boundaries.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chen et al., 2019 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThese methods commonly investigate differences in early, middle, and late fusion, and work has been done to address view-missing and view-heterogeneity problems.
“These methods also commonly investigate differences in “early”, “middle”, and “late” fusion and work has even been done to address the view-missing and view-heterogeneity problems (Nagrani et al., 2018; Wang et al., 2020).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenThe criteria of sets of features from distinct views across a shared set of samples is applicable to any domain where the combination of different data sources provides a more complete representation of the system under investigation.
“The criteria of sets of features from distinct views across a shared set of samples is applicable to any domain where the combination of different data sources provides a more complete representation of the system under investigation.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningDependencies exist between different omics data, but important differences between omics must also be accounted for in developed integrative approaches.
“On the other hand, though dependencies exist between different ‘omics data, important differences between ‘omics must also be accounted for in developed integrative approaches.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn untargeted metabolomics and lipidomics, false discovery rates are difficult to compute and largely not accurate.
“In untargeted metabolomics and lipidomics false discovery rates are difficult to compute and largely not accurate (Stein, 1994; Jeong et al., 2011; Matsuda et al., 2013; Kim and Zhang, 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMONET incorporates partially observed samples by representing their missing components as edgeless nodes within their corresponding edge-weighted graphs.
“This algorithm incorporates partially observed samples by representing their missing components as edgeless nodes within their corresponding edge-weighted graphs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rappoport et al., 2020 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningLow-sample-size cases present the need for methods that generate reliable inference despite smaller sample sizes and avoid overfitting to the data.
“These cases present the need for methods that generate reliable inference despite smaller sample sizes and avoid overfitting to the data.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMany of the deep-learning architectures mentioned in this review have similarities to ones used in analysis of digital media that try to combine multiple modalities to improve predictive performance of video content.
“many of the deep-learning architectures mentioned in this review have similarities to ones used in analysis of digital media that try to combine multiple modalities to improve predictive performance of video content (Carreira and Zisserman, 2017; Afouras et al., 2019).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationA study to identify biomarkers for Snyder Robinson syndrome obtained data on 16 patients, only three of which presented with the disorder of interest.
“For example, a study to identify biomarkers for Snyder Robinson syndrome, a rare neurological disorder, obtained data on 16 patients, only three of which presented with the disorder of interest (Abela et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abela et al., 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationManual verification of metabolites following identification scoring is required for shotgun metabolomics because scoring methods are much less mature than for other omics data types.
“manual verification of metabolites following identification scoring is required for shotgun metabolomics, as scoring methods are much less mature than for other ‘omics data types (Stein and Scott, 1994; Samaraweera et al., 2018).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Stein and Scott, 1994
Not checked in the free run.
- cites Samaraweera et al., 2018 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe larger sample size requirement is implicit because it is rarely stated as a limitation but is implied by the sample sizes of the datasets these methods were successfully applied to.
“We describe this requirement as “implicit” given that it is rarely, if ever, stated as a limitation, but instead implied based on the sample sizes of the datasets that these methods were successfully applied to.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationUsing AUROC on TCGA and CCLE benchmark datasets, DeepIMV's performance diminished with increased missingness but performed as well as or better than compared approaches.
“Using the area under the receiver-operator curve (AUROC) as a performance metric, the authors found that the performance of DeepIMV diminished with increased missingness but performed as well as or better than the compared approaches.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee and van der Schaar, 2021
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBIDIFAC+ took nearly 24 hours to reach convergence when fitted to a combined TCGA dataset, and thus may not scale well with larger aggregations of datasets.
“As well, they noted that BIDIFAC+ took nearly 24 h to reach convergence when fitted to a combined TCGA dataset, and thus the method may not scale well with larger aggregations of datasets.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lock et al., 2022 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAround 19 samples per group are needed to detect a fold change of 1.5 in microRNA data at 80% power and false discovery rate <10%.
“Kok et al. (2018) notes, for example, that one may need around 19 samples per group to detect a fold change of 1.5 in microRNA data at 80% power and false discovery rate <10%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kok et al., 2018 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningInsights from the omics domain, where some of these issues are most salient, could transfer to other domains.
“Insights from the ‘omics domain, where some of these issues are most salient, could transfer to other domains.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenThe methodological choices inherent to the omics domain are usually the ones that offer the ability to constrain or elucidate relationships between biomarkers.
“The methodological choices inherent to the ‘omics domain are usually the ones that offer the ability to constrain or elucidate relationships between biomarkers.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe groupings implicit within the latent factors generated by these models may be contextualized according to domain-specific knowledge, thus increasing their interpretability and allowing one to infer underlying relationships.
“the groupings implicit within the latent factors generated by these models may be contextualized according to domain-specific knowledge (e.g., shared molecular pathways), thus increasing their interpretability and allowing one to infer underlying relationships.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenCommon methodological choices in the omics domain include principal-component-like representations that might identify important groups of biomarkers, and injection of prior knowledge through techniques that constrain relationships between features, such as directed edges in graph representations, hard parameter constraints, or carefully chosen priors in Bayesian frameworks.
“Some common choices are the use of principal-component-like representations that might identify important groups of biomarkers, and the injection of prior knowledge through techniques that constrain the relationships between features such as directed edges in graph representations, hard parameter constraints, or carefully chosen priors in”
- Also stated in: § Discussion · plain
“the relationships between features such as directed edges in graph representations, hard parameter constraints, or carefully chosen priors in Bayesian frameworks.”
Quote in the paperNot a substantial claim- Also stated in: § Discussion · plain
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningIncorporating domain knowledge may be key toward bridging the interpretability gap apparent across these methods.
“incorporating domain knowledge may be key toward bridging the interpretability gap apparent across these methods.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningIf the generation of these latent factors were instead guided by domain knowledge, resulting groupings may be more likely to hold relevance and rely less on post-hoc analyses for contextualization within the scientific domain.
“If the generation of these latent factors were instead guided by domain knowledge, resulting groupings may be more likely to hold relevance and rely less on post-hoc analyses for contextualization”
- Also stated in: § Discussion · hedged
“instead guided by domain knowledge, resulting groupings may be more likely to hold relevance and rely less on post-hoc analyses for contextualization within the scientific domain.”
Quote in the paperNot a substantial claim- Also stated in: § Discussion · hedged
The paper relies on this without support.
Existing multi-omics data integration review articles either do not address or only briefly mention methods for handling missing observations.
“Despite the importance of considering methods for handling missing observations, this topic is either not addressed or is only briefly mentioned in existing multi-omics data integration review articles.”
The authors state this as an assumption.
The iBAG approach assumes completely observed data.
“The iBAG approach assumes completely observed data, and to remedy this, the FBM approach introduces a third, imputation layer that models missing gene expression and methylation data through multivariate normal distributions.”
The authors state this as an assumption.
The FBM model assumes gene-gene and methylation-methylation independence, and imputed values reflect this assumption.
“Also worth noting is that the FBM model assumes gene-gene and methylation-methylation independence and imputed values reflect this assumption accordingly.”
The authors state this as an assumption.
MVAE assumes that data views are independent from one another, given a shared latent representation.
“One key assumption made by this approach is that data views are independent from one another, given a shared latent representation.”
The authors state this as an assumption.
BIDIFAC+ assumes that shared structures are present across the integrated matrices.
“Lock et al. (2022) note that BIDIFAC+ assumes that shared structures are present across the integrated matrices, an assumption that may be violated in practice.”
The paper relies on this without support.
The known causal hierarchy across biomolecules is that genotype affects omic expression, which influences phenotype.
“The proposed framework is aligned with the known causal hierarchy across these biomolecules, i.e., genotype affects ‘omic expression which influences phenotype.”
The paper relies on this without support.
Gene expression is known to be affected by changes to the DNA sequence.
“For example, gene expression is known to be affected by changes to the DNA sequence.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Non-learning-based imputation methods can introduce bias and reduce data variability.
“Although these methods are simple and easy to implement, they can introduce bias and reduce data variability (Flores et al., 2023).”
From Navigating the landscape of multimodal AI in medicine: A scoping review on technical challenges and clinical applications (2025) · cites this paper as Flores et al., 2023
Cites
Maximum Likelihood from Incomplete Data Via the <i>EM</i> Algorithm
Dempster, A. P., Laird, N. M., & Rubin, D. B. (1977) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1977.tb01600.x · Cited by 50,444 · cited 2× · see citing works
“Missing ‘omics data are accommodated through an expectation-maximization (EM) approach (Dempster et al., 1977) for parameter estimation.”
MethodOn Information and Sufficiency
Kullback, S., & Leibler, R. A. (1951) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729694 · Cited by 20,193 · see citing works
Auto-Encoding Variational Bayes
Kingma, D. P., & Welling, M. (2013) · arXiv · doi:10.48550/arxiv.1312.6114 · Cited by 20,067 · see citing works
<b>mice</b>: Multivariate Imputation by Chained Equations in<i>R</i>
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870 · see citing works
Data Analysis Using Regression and Multilevel/Hierarchical Models
Gelman, A., & Hill, J. (2006) · doi:10.1017/cbo9780511790942 · Cited by 13,597 · see citing works
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925 · see citing works
Quo Vadis, Action Recognition? A New Model and the Kinetics Dataset
Carreira, J., & Zisserman, A. (2017) · 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2017.502 · Cited by 9,570 · cited 1× · see citing works
“For example, many of the deep-learning architectures mentioned in this review have similarities to ones used in analysis of digital media that try to combine multiple modalities to improve predictive performance of video content (Carreira and Zisserman, 2017; Afouras et al., 2019).”
Hanrahan, G. (2008) · CRC Press eBooks · doi:10.1201/9781420067972-10 · Cited by 8,196 · see citing works
(2010) · Cited by 7,034 · see citing works
Missing Value Estimation Methods for DNA Microarrays
Troyanskaya, O., Cantor, M., Sherlock, G., Brown, P., Hastie, T., Tibshirani, R., Botstein, D., & Altman, R. B. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.6.520 · Cited by 4,230 · see citing works
The information bottleneck method
Tishby, N., Pereira, F. C., & Bialek, W. (2000) · arXiv · doi:10.48550/arxiv.physics/0004057 · Cited by 2,626 · cited 1× · see citing works
“DeepIMV’s latent mappings are trained according to the informational bottleneck principle (Tishby et al., 2000; Alemi et al., 2016; Achille and Soatto, 2017), which seeks to define task-relevant data representations that respect the balance between parsimony and predictive power.”
BackgroundFast Kd-Trees for the Kullback-Leibler Divergence and Other Decomposable Bregman Divergences
Pham, T., & Wagner, H. (2025) · Leibniz international proceedings in informatics · doi:10.4230/lipics.wads.2025.45 · Cited by 2,353 · see citing works
Quasi-likelihood functions, generalized linear models, and the gauss-newton method
Wedderburn, R. W. M. (1974) · Biometrika · doi:10.2307/2334725 · Cited by 2,122 · see citing works
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867 · cited 1× · see citing works
“Finally, additional sources of uncertainty may arise from processes such as protein quantification in bottom-up proteomics (Rifai et al., 2006; Plubell et al., 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al.”
BackgroundMultiple Kernel Learning Algorithms
Gönen, M., & Alpaydın, E. (2011) · Cited by 1,651 · see citing works
Multi-omics Data Integration, Interpretation, and Its Application
Subramanian, I., Verma, S., Kumar, S., Jere, A., & Anamika, K. (2020) · Bioinformatics and Biology Insights · doi:10.1177/1177932219899051 · Cited by 1,609 · cited 1× · see citing works
“…‘omics data types, such as single cell ‘omics (Ma et al., 2020) or specific application areas, such as plant biology (Rajasundaram and Selbig, 2016), microbial communities (Fondi and Liò, 2015; Franzosa et al., 2015), cancer (Buescher and Driggers, 2016), and others (e.g., Subramanian et al., 2020).”
BackgroundMulti-Omics Factor Analysis—a framework for unsupervised integration of multi-omics data sets
Argelaguet, R., Velten, B., Arnol, D., Dietrich, S., Zenz, T., Marioni, J. C., Buettner, F., Huber, W., & Stegle, O. (2018) · Molecular Systems Biology · doi:10.15252/msb.20178124 · Cited by 1,510 · see citing works
Deep Variational Information BottleneckPreprint
Alemi, A. A., Fischer, I., Dillon, J. V., & Murphy, K. P. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1612.00410 · Cited by 1,291 · cited 1× · see citing works
“DeepIMV’s latent mappings are trained according to the informational bottleneck principle (Tishby et al., 2000; Alemi et al., 2016; Achille and Soatto, 2017), which seeks to define task-relevant data representations that respect the balance between parsimony and predictive power.”
BackgroundMOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data
Argelaguet, R., Arnol, D., Bredikhin, D., Deloro, Y., Velten, B., Marioni, J. C., & Stegle, O. (2020) · Genome Biology · doi:10.1186/s13059-020-02015-1 · Cited by 1,091 · cited 1× · see citing works
“, 2018) and its more recent improvement, MOFA+ (Argelaguet et al., 2020) are unsupervised integrative approaches that may be understood as generalizations of principal components analysis (PCA) to multi-omics data.”
BackgroundMethods of integrating data to uncover genotype-phenotype interactions
Ritchie, M. D., Holzinger, E. R., Li, R., Pendergrass, S. A., & Kim, D. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3868 · Cited by 1,085 · cited 1× · see citing works
“A sensible partition is of early, middle, and late integrative methods, alternatively denoted as concatenation, transformation-based, or model-based integration, respectively (Ritchie et al., 2015).”
BackgroundDIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays
Singh, A., Shannon, C. P., Gautier, B., Rohart, F., Vacher, M. A., Tebbutt, S. J., & Cao, K. L. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty1054 · Cited by 1,079 · see citing works
Spectral Regularization Algorithms for Learning Large Incomplete Matrices.
Mazumder, R., Hastie, T. J., & Tibshirani, R. J. (2010) · PubMed · Cited by 1,058 · see citing works
Epidemiologic evaluation of measurement data in the presence of detection limits
Lubin, J. H., Colt, J. S., Camann, D., Davis, S., Cerhan, J. R., Severson, R. K., Bernstein, L., & Hartge, P. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.7199 · Cited by 1,021 · see citing works
Using machine learning approaches for multi-omics data analysis: A review
Reel, P. S., Reel, S., Pearson, E., Trucco, E., & Jefferson, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107739 · Cited by 903 · cited 1× · see citing works
“…of subsets of general AI and ML approaches to multi-omics data integration (e.g., Li et al., 2016; Huang et al., 2017; Kim and Tagkopoulos, 2018; Picard et al., 2021; Reel et al., 2021; Lee and Kim, 2022) with some attention given to limitations of methods, such as interpretability of models.”
MethodOptimization and testing of mass spectral library search algorithms for compound identification
Stein, S. E., & Scott, D. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)87009-8 · Cited by 882 · cited 2× · see citing works
“In untargeted metabolomics and lipidomics false discovery rates are difficult to compute and largely not accurate (Stein, 1994; Jeong et al., 2011; Matsuda et al., 2013; Kim and Zhang, 2014).”
MethodDeep Audio-Visual Speech Recognition
Afouras, T., Chung, J. S., Senior, A., Vinyals, O., & Zisserman, A. (2022) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2018.2889052 · Cited by 801 · cited 1× · see citing works
“For example, many of the deep-learning architectures mentioned in this review have similarities to ones used in analysis of digital media that try to combine multiple modalities to improve predictive performance of video content (Carreira and Zisserman, 2017; Afouras et al., 2019).”
Canonical analysis of several sets of variables
Kettenring, J. R. (1971) · Biometrika · doi:10.1093/biomet/58.3.433 · Cited by 798 · cited 3× · see citing works
“When α = 0 the JACA loss reduces to that of CCA or SUMCOR multiset CCA (Kettenring, 1971) with sparsity regularization, depending on whether three or more ‘omics are under consideration.”
BackgroundSequencing and beyond: integrating molecular 'omics' for microbial community profiling
Franzosa, E. A., Hsu, T. Y., Sirota‐Madi, A., Shafquat, A., Abu-Ali, G., Morgan, X. C., & Huttenhower, C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3451 · Cited by 725 · cited 1× · see citing works
“, 2020) or specific application areas, such as plant biology (Rajasundaram and Selbig, 2016), microbial communities (Fondi and Liò, 2015; Franzosa et al., 2015), cancer (Buescher and Driggers, 2016), and others (e.”
BackgroundMissing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data
Wei, R., Wang, J., Su, M., Jia, E., Chen, S., Chen, T., & Ni, Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-19120-0 · Cited by 720 · cited 2× · see citing works
“When an assumption of MCAR or MAR is used, the missingness is said to be ignorable and methods designed to handle missing values are applied to both cases (Gelman and Hill, 2006; Fang et al., 2018; Wei et al., 2018).”
BackgroundMethodIntegration strategies of multi-omics data for machine learning analysis
Picard, M., Scott-Boyer, M.-P., Bodein, A., Périn, O., & Droit, A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.030 · Cited by 696 · cited 5× · see citing works
“Picard et al. (2021) further separate the early-middle-late categorization into early, mixed, late, intermediate, and hierarchical.”
BackgroundMethodInfluentialMolecular Biologist's Guide to Proteomics
Graves, P. R., & Haystead, T. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.1.39-63.2002 · Cited by 691 · cited 1× · see citing works
“Proteomics instrumentation can measure the relative abundance of proteins that are produced from gene expression and transcript translation (Graves and Haystead, 2002).”
BackgroundIntegrated omics: tools, advances and future approaches
Misra, B. B., Langefeld, C., Olivier, M., & Cox, L. A. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0055 · Cited by 686 · cited 2× · see citing works
“However, data integration is one of the primary barriers to effective multi-omics research and reaching the desired holistic view of the biological system being studied (Misra et al., 2019).”
BackgroundSpectral Regularization Algorithms for Learning Large Incomplete Matrices
MazumderRahul, HastieTrevor, & TibshiraniRobert (2010) · Journal of Machine Learning Research · doi:10.5555/1756006.1859931 · Cited by 671 · cited 1× · see citing works
“As a joint-imputation approach, MOFA/MOFA + was compared to other imputation strategies including imputation by feature-wise mean, SoftImpute (Mazumder et al., 2010) and a k-nearest neighbor approach (Troyanskaya et al., 2001).”
MethodAnalyzing Compositional Data with R
van den Boogaart, K. G., & Tolosana‐Delgado, R. (2013) · Springer eBooks · doi:10.1007/978-3-642-36809-7 · Cited by 661 · see citing works
More Is Better: Recent Progress in Multi-Omics Data Integration Methods
Huang, S., Chaudhary, K., & Garmire, L. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00084 · Cited by 637 · cited 1× · see citing works
“…a handful of reviews are dedicated to discussion of subsets of general AI and ML approaches to multi-omics data integration (e.g., Li et al., 2016; Huang et al., 2017; Kim and Tagkopoulos, 2018; Picard et al., 2021; Reel et al., 2021; Lee and Kim, 2022) with some attention given to limitations of…”
BackgroundWhat Makes Training Multi-modal Classification Networks Hard?
Wang, W., Tran, D., & Feiszli, M. (2020) · 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr42600.2020.01271 · Cited by 588 · see citing works
Joint and individual variation explained (JIVE) for integrated analysis of multiple data types
Lock, E. F., Hoadley, K. A., Marron, J. S., & Nobel, A. B. (2013) · The Annals of Applied Statistics · doi:10.1214/12-aoas597 · Cited by 554 · cited 1× · see citing works
“BIDIFAC+ builds upon BIDIFAC (Park and Lock, 2019) and SLIDE (Gaynanova and Li, 2019), two extensions of the JIVE method (Lock et al., 2013) that yields matrix factorizations that convey a decomposition of data variability into variability shared across multiple ‘omics and variability primarily attributable to single…”
MethodLazar, C., Gatto, L., Ferro, M., Bruley, C., & Bürger, T. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00981 · Cited by 532 · see citing works
Comparison of performance of data imputation methods for numeric dataset
Jadhav, A., Pramod, D., & Ramanathan, K. (2019) · Applied Artificial Intelligence · doi:10.1080/08839514.2019.1637138 · Cited by 471 · see citing works
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455 · cited 2× · see citing works
“Machine learning (ML) and artificial intelligence (AI) have shown promise in overcoming some of these hindrances (e.g., Mirza et al., 2019; Zhu, 2020) and have gained popularity in recent years.”
BackgroundMethods for the integration of multi-omics data: mathematical aspects
Bersanelli, M., Mosca, E., Remondini, D., Giampieri, E., Sala, C., Castellani, G., & Milanesi, L. (2016) · BMC Bioinformatics · doi:10.1186/s12859-015-0857-9 · Cited by 449 · cited 1× · see citing works
“Some reviews focus on differentiating general data-driven integration approaches from a mathematical perspective (e.g., Ritchie et al., 2015; Bersanelli et al., 2016; Noor et al., 2019), focus on a particular type of method, such as dimension reduction (Meng et al.”
BackgroundA review on machine learning principles for multi-view biological data integration
Li, Y., Wu, F., & Ngom, A. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw113 · Cited by 425 · see citing works
MOLI: multi-omics late integration with deep neural networks for drug response prediction
Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C., & Ester, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz318 · Cited by 421 · cited 1× · see citing works
“Another example, MOLI (Sharifi-Noghabi et al., 2019), similarly processes each view separately through a DNN and concatenates The vast majority of these integration approaches require completely observed data for their implementation.”
BackgroundData integration in the era of omics: current and future challenges
Gómez-Cabrero, D., Abugessaisa, I., Maier, D., Teschendorff, A. E., Merkenschlager, M., Gisel, A., Ballestar, E., Bongcam‐Rudloff, E., Conesa, A., & Tegner, J. N. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-s2-i1 · Cited by 411 · see citing works
Artificial intelligence for proteomics and biomarker discovery
Mann, M., Kumar, C., Zeng, W., & Strauss, M. T. (2021) · Cell Systems · doi:10.1016/j.cels.2021.06.006 · Cited by 390 · see citing works
A roadmap for multi-omics data integration using deep learning
Kang, M., Ko, E., & Mersha, T. B. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab454 · Cited by 389 · see citing works
Dimension reduction techniques for the integrative analysis of multi-omics data
Meng, C., Zeleznik, O. A., Thallinger, G., Küster, B., Gholami, A. M., & Culhane, A. C. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv108 · Cited by 383 · cited 1× · see citing works
“, 2019), focus on a particular type of method, such as dimension reduction (Meng et al., 2016), or compare data-driven models against biologically-informed models for a particular model type, such as networkmodels (Wanichthanarak et al.”
MethodMachine learning and integrative analysis of biomedical big data
Mirza, B., Wang, W., Wang, J., Choi, H., Chung, N. C., & Ping, P. (2019) · Genes · doi:10.3390/genes10020087 · Cited by 380 · cited 1× · see citing works
“Machine learning (ML) and artificial intelligence (AI) have shown promise in overcoming some of these hindrances (e.g., Mirza et al., 2019; Zhu, 2020) and have gained popularity in recent years.”
BackgroundRegularized Generalized Canonical Correlation Analysis
Tenenhaus, A., & Tenenhaus, M. (2011) · Psychometrika · doi:10.1007/s11336-011-9206-8 · Cited by 367 · see citing works
State of the field in multi-omics research: from computational needs to data mining and sharing
Krassowski, M., Das, V., Sahu, S. K., & Misra, B. B. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.610798 · Cited by 351 · cited 1× · see citing works
“This is as opposed to other (larger) transcriptomics platforms that would require at least 35 samples per group to detect the same magnitude fold change at the same power and false discovery rate levels (Krassowski et al., 2020).”
BackgroundMachine learning for multi-omics data integration in cancer
Cai, Z., Poulos, R. C., Liu, J., & Zhong, Q. (2022) · iScience · doi:10.1016/j.isci.2022.103798 · Cited by 341 · cited 1× · see citing works
“, 2022) and a majority focused on cancer research (e.g., Wang and Gu, 2016; Biswas and Chakrabarti, 2020; Nicora et al., 2020; Cai et al., 2022).”
BackgroundSun, D., Wang, M., & Li, A. (2019) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2806438 · Cited by 338 · cited 1× · see citing works
“Late integration examples include the method introduced by Sun et al. (2019) that processes each ‘omic type separately through a deep neural network (DNN) and then performs score fusion on the predictions.”
MethodA multivariate approach to the integration of multi-omics datasets
Meng, C., Küster, B., Culhane, A. C., & Gholami, A. M. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-162 · Cited by 319 · cited 1× · see citing works
“These generally form viewspecific representations and assume a common latent space among views (Yang and Michailidis, 2015; Chalise and Fridley, 2017) or maximize some measure among the view-specific representations (Tenenhaus and Tenenhaus, 2011;Meng et al., 2014; Tenenhaus et al., 2017; Singh et al., 2019).”
BackgroundYang, Z., & Michailidis, G. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv544 · Cited by 295 · cited 1× · see citing works
“These generally form view-specific representations and assume a common latent space among views (Yang and Michailidis, 2015; Chalise and Fridley, 2017) or maximize some measure among the view-specific representations (Tenenhaus and Tenenhaus, 2011; Meng et al., 2014; Tenenhaus et al., 2017; Singh et…”
BackgroundWebb-Robertson, B.-J. M., Wiberg, H. K., Matzke, M. M., Brown, J. N., Wang, J., McDermott, J. E., Smith, R. D., Rodland, K. D., Metz, T. O., Pounds, J. G., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501138h · Cited by 294 · see citing works
Self-citationDevelopment, characterization and comparisons of targeted and non-targeted metabolomics methods
Ribbenstedt, A., Ziarrusta, H., & Benskin, J. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207082 · Cited by 291 · cited 1× · see citing works
“, stationary phase and ionization mode) induces increased instrumental sensitivity toward some substances and reductions toward others (Ribbenstedt et al., 2018).”
BackgroundThe chromosome-centric human proteome project for cataloging proteins encoded in the genome
Paik, Y.-K., Jeong, S.-K., Omenn, G. S., Uhlen, M., Hanash, S., Cho, S. Y., Lee, H.-J., Na, K., Choi, E.-Y., Yan, F., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2152 · Cited by 288 · cited 1× · see citing works
“For example, the human proteome project reports that an estimated ∼20% of genes yield protein products that are not detected by mass spectrometry, an analytic platform for protein quantification (Paik et al., 2012; Baker et al., 2017).”
BackgroundNEMO: cancer subtyping by integration of partial multi-omic data
Rappoport, N., & Shamir, R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz058 · Cited by 286 · cited 1× · see citing works
“Neighborhood based Multi-Omics clustering (NEMO; Rappoport and Shamir, 2019) is an algorithm that generates clusters based on individual data view similarity matrices.”
Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools
Nicora, G., Vitali, F., Dagliati, A., Geifman, N., & Bellazzi, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01030 · Cited by 284 · see citing works
Integrative Methods and Practical Challenges for Single-Cell Multi-omics
Ma, A., McDermaid, A., Xu, J., Chang, Y., & Ma, Q. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.02.013 · Cited by 272 · cited 1× · see citing works
“On the other hand, many of these articles focus on integration for specific ‘omics data types, such as single cell ‘omics (Ma et al., 2020) or specific application areas, such as plant biology (Rajasundaram and Selbig, 2016), microbial communities (Fondi and Liò, 2015; Franzosa et al.”
BackgroundChalise, P., & Fridley, B. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176278 · Cited by 233 · cited 1× · see citing works
“These generally form view-specific representations and assume a common latent space among views (Yang and Michailidis, 2015; Chalise and Fridley, 2017) or maximize some measure among the view-specific representations (Tenenhaus and Tenenhaus, 2011; Meng et al., 2014; Tenenhaus et al., 2017; Singh et…”
BackgroundEstimating probabilities of correct identification from results of mass spectral library searches
Stein, S. E. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)85022-4 · Cited by 231 · see citing works
Artificial Intelligence (AI)-Based Systems Biology Approaches in Multi-Omics Data Analysis of Cancer
Biswas, N., & Chakrabarti, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.588221 · Cited by 217 · cited 1× · see citing works
“…engineering ( Helmy et al., 2020), precision medicine (Hamamoto et al., 2019), amongst others (e.g., Mann et al., 2021; Lin et al., 2022; Zhou et al., 2022) and a majority focused on cancer research (e.g., Wang and Gu, 2016; Biswas and Chakrabarti, 2020; Nicora et al., 2020; Cai et al., 2022).”
BackgroundGaussian mixture clustering and imputation of microarray data
Ouyang, M., Welsh, W. J., & Georgopoulos, P. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth007 · Cited by 202 · cited 1× · see citing works
“It has been shown that missing values in large-scale ‘omics data can hinder downstream analyses (Ouyang et al., 2004; Jörnsten et al., 2005).”
BackgroundMultimodal Generative Models for Scalable Weakly-Supervised Learning
Wu, M., & Goodman, N. (2018) · arXiv · doi:10.48550/arxiv.1802.05335 · Cited by 200 · cited 2× · see citing works
“DeepIMV (Lee and van der Schaar, 2021) incorporates some of the principles utilized by Wu and Goodman (2018) to develop a deep variational information bottleneck approach that maps integrated, multi-omics data into a lower-dimensional subspace of task-relevant embeddings.”
BackgroundMethodMultibatch TMT reveals false positives, batch effects and missing values
Brenes, A., Hukelmann, J., Bensaddek, D., & Lamond, A. I. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001472 · Cited by 196 · cited 1× · see citing works
“It is not uncommon to have 20–50% of the possible peptide values that are not quantified (WebbRobertson et al., 2015; Brenes et al., 2019).”
BackgroundImputation of data values that are less than a detection limit
Succop, P. A., Clark, S., Chen, M., & Galke, W. (2004) · Journal of Occupational and Environmental Hygiene · doi:10.1080/15459620490462797 · Cited by 185 · cited 1× · see citing works
“However, like mean imputation, imputed values from these approaches may distort feature distributions and lead to biased parameter and variability estimates (Lubin et al., 2004; Succop et al., 2004; Webb-Robertson et al., 2015; Lazar et al., 2016; Bramer et al., 2020).”
BackgroundMachine learning meets omics: applications and perspectives
Li, R., Li, L., Xu, Y., & Yang, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab460 · Cited by 180 · cited 1× · see citing works
“Included in these are articles discussing examples of method application (e.g., Holzinger et al., 2019; Li et al., 2021) and challenges in applying AI and ML techniques to multi-omics data (e.g., Kang et al., 2021; Termine et al., 2021).”
MethodTenenhaus, M., Tenenhaus, A., & Groenen, P. J. F. (2017) · Psychometrika · doi:10.1007/s11336-017-9573-x · Cited by 177 · cited 1× · see citing works
“…form view-specific representations and assume a common latent space among views (Yang and Michailidis, 2015; Chalise and Fridley, 2017) or maximize some measure among the view-specific representations (Tenenhaus and Tenenhaus, 2011; Meng et al., 2014; Tenenhaus et al., 2017; Singh et al., 2019).”
BackgroundA statistical framework for protein quantitation in bottom-up MS-based proteomics
Karpievitch, Y., Stanley, J., Taverner, T., Huang, J., Adkins, J. N., Ansong, C., Heffron, F., Metz, T. O., Qian, W.-J., Yoon, H., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp362 · Cited by 176 · see citing works
Genomic, Proteomic, and Metabolomic Data Integration Strategies
Wanichthanarak, K., Fahrmann, J. F., & Grapov, D. (2015) · Biomarker Insights · doi:10.4137/bmi.s29511 · Cited by 170 · cited 1× · see citing works
“…2019), focus on a particular type of method, such as dimension reduction (Meng et al., 2016), or compare data-driven models against biologically-informed models for a particular model type, such as network models (Wanichthanarak et al., 2015) with little attention on particular ‘omics data types.”
BackgroundMulti -omics and metabolic modelling pipelines: Challenges and tools for systems microbiology
Fondi, M., & Lió, P. (2015) · Microbiological Research · doi:10.1016/j.micres.2015.01.003 · Cited by 166 · see citing works
Efficient co-regularised least squares regression
Brefeld, U., Gärtner, T., Scheffer, T., et al. (2006) · International Conference on Machine Learning · doi:10.1145/1143844.1143862 · Cited by 154 · cited 1× · see citing works
“Similar co-regularization approaches for semisupervised multi-omic or (more generally) multi-view learning have been previously introduced (Sindhwani et al., 2005; Brefeld et al., 2006; Sun and Shawe-Taylor, 2010).”
BackgroundiBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data
Wang, W., Baladandayuthapani, V., Morris, J. S., Broom, B. M., Manyam, G. C., & Do, K.-A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts655 · Cited by 154 · see citing works
Learnable PINs: cross-modal embeddings for person identity
Nagrani, A., Albanie, S., & Zisserman, A. (2018) · Lecture notes in computer science · doi:10.1007/978-3-030-01261-8_5 · Cited by 151 · cited 1× · see citing works
“These methods also commonly investigate differences in “early”, “middle”, and “late” fusion and work has even been done to address the view-missing and view-heterogeneity problems (Nagrani et al., 2018; Wang et al., 2020).”
MethodWhy imaging data alone is not enough: AI-based integration of imaging, omics, and clinical data
Holzinger, A., Haibe‐Kains, B., & Jurišica, I. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04382-9 · Cited by 140 · cited 1× · see citing works
“Included in these are articles discussing examples of method application (e.g., Holzinger et al., 2019; Li et al., 2021) and challenges in applying AI and ML techniques to multi-omics data (e.g., Kang et al., 2021; Termine et al., 2021).”
MethodHelmy, M., Smith, D. J., & Selvarajoo, K. (2020) · Metabolic Engineering Communications · doi:10.1016/j.mec.2020.e00149 · Cited by 135 · see citing works
A Review of Integrative Imputation for Multi-Omics Datasets
Song, M., Greenbaum, J., Luttrell, J., Zhou, W., Wu, C., Shen, H., Gong, P., Zhang, C., & Deng, H.-W. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.570255 · Cited by 127 · see citing works
Hamamoto, R., Komatsu, M., Takasawa, K., Asada, K., & Kaneko, S. (2019) · Biomolecules · doi:10.3390/biom10010062 · Cited by 126 · see citing works
Xu, J., Wu, P., Chen, Y., Meng, Q., Dawood, H., & Dawood, H. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3116-7 · Cited by 123 · cited 1× · see citing works
“For contrast, another deep learning-based method (Xu et al., 2019) trains separate networks that see only the data from a particular view and then fuses the hidden representations at some intermediate layer.”
BackgroundDNA microarray data imputation and significance analysis of differential expression
Jörnsten, R., Wang, H.-Y., Welsh, W. J., & Ouyang, M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti638 · Cited by 121 · cited 1× · see citing works
“It has been shown that missing values in large-scale ‘omics data can hinder downstream analyses (Ouyang et al., 2004; Jörnsten et al., 2005).”
BackgroundUnsupervised multiple kernel learning for heterogeneous data integration
Mariette, J., & Vialaneix, N. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx682 · Cited by 120 · see citing works
Integration of omics: more than the sum of its parts
Buescher, J. M., & Driggers, E. M. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0143-y · Cited by 119 · cited 1× · see citing works
“…‘omics data types, such as single cell ‘omics (Ma et al., 2020) or specific application areas, such as plant biology (Rajasundaram and Selbig, 2016), microbial communities (Fondi and Liò, 2015; Franzosa et al., 2015), cancer (Buescher and Driggers, 2016), and others (e.g., Subramanian et al., 2020).”
BackgroundCPM-Nets: Cross Partial Multi-View Networks
Zhang, C., Han, Z., Cui, Y., Fu, H., Zhou, J. T., & Hu, Q. (2019) · neural information processing systems · Cited by 114 · see citing works
iOmicsPASS: network-based integration of multiomics data for predictive subnetwork discovery
Koh, H. W. L., Fermin, D., Vogel, C., Choi, K. P., Ewing, R. M., & Choi, H. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0099-y · Cited by 113 · see citing works
Missing data imputation through the use of the random forest algorithm
Pantanowitz, A., & Marwala, T. (2009) · Advances in Intelligent and Soft Computing · doi:10.1007/978-3-642-03156-4_6 · Cited by 106 · cited 1× · see citing works
“Other common imputation approaches include random forest imputation (Pantanowitz and Marwala, 2009) and expectation maximization (Dempster et al.”
Kok, M. G. M., de Ronde, M. W. J., Moerland, P. D., Ruijter, J. M., Creemers, E. E., & Pinto-Sietsma, S. J. (2018) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2017.11.002 · Cited by 105 · see citing works
Evaluating and minimizing batch effects in metabolomics
Han, W., & Li, L. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21672 · Cited by 105 · cited 1× · see citing works
“For example, batch effects are common and often much more pronounced in mass spectrometry-based data (Mertens, 2016; Phua et al., 2022; e.g., Han and Li, 2020), even when the same physical instrument is used and the same data type is being generated.”
BackgroundGroup lasso regularized deep learning for cancer prognosis from multi-omics and clinical features
Xie, G., Dong, C., Kong, Y., Zhong, J. F., Li, M., & Wang, K. (2019) · Genes · doi:10.3390/genes10030240 · Cited by 102 · cited 1× · see citing works
“Xie et al. (2019) use deep learning to perform survival analysis, which involves feature selection by removing observations with high missingness, early concatenation of raw features to form the input to their model, and implicit feature extraction using deep neural networks, as the value at each…”
MethodnetDx: interpretable patient classification using integrated patient similarity networks
Pai, S., Hui, S., Isserlin, R., Shah, M. A., Kaka, H., & Bader, G. D. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188497 · Cited by 102 · see citing works
Accelerating the search for the missing proteins in the human proteome
Baker, M. S., Ahn, S. B., Mohamedali, A., Islam, M. T., Cantor, D., Verhaert, P. D., Fanayan, S., Sharma, S., Nice, E. C., Connor, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14271 · Cited by 100 · cited 1× · see citing works
“For example, the human proteome project reports that an estimated ∼ 20% of genes yield protein products that are not detected by mass spectrometry, an analytic platform for protein quantification (Paik et al., 2012; Baker et al., 2017).”
BackgroundData integration and predictive modeling methods for multi-omics datasets
Kim, M., & Tagkopoulos, I. (2017) · Molecular Omics · doi:10.1039/c7mo00051k · Cited by 99 · see citing works
Sparse Semi-supervised Learning Using Conjugate Functions
Sun, S., & Shawe-Taylor, J. S. (2010) · Cited by 92 · see citing works
Plubell, D. L., Käll, L., Webb-Robertson, B.-J., Bramer, L. M., Ives, A., Kelleher, N. L., Smith, L. M., Montine, T. J., Wu, C. C., & MacCoss, M. J. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00894 · Cited by 85 · cited 1× · see citing works
“Finally, additional sources of uncertainty may arise from processes such as protein quantification in bottom-up proteomics (Rifai et al., 2006; Plubell et al., 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al., 2011; Webb-Robertson et al.,…”
BackgroundSelf-citationBiological insights through omics data integration
Noor, E., Cherkaoui, S., & Sauer, U. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.03.007 · Cited by 83 · cited 2× · see citing works
“…methods such as graph representations or other hard constraints on parameter representations with machine learning methods are ongoing (Noor et al., 2019; Lee and Kim, 2022), and evaluation and development of mechanisms for handling missing data within these frameworks will be…”
MethodIntegrative clustering methods of multi‐omics data for molecule‐based cancer classifications
Wang, D., & Gu, J. (2016) · Quantitative Biology · doi:10.1007/s40484-016-0063-4 · Cited by 81 · cited 1× · see citing works
“…engineering ( Helmy et al., 2020), precision medicine (Hamamoto et al., 2019), amongst others (e.g., Mann et al., 2021; Lin et al., 2022; Zhou et al., 2022) and a majority focused on cancer research (e.g., Wang and Gu, 2016; Biswas and Chakrabarti, 2020; Nicora et al., 2020; Cai et al., 2022).”
BackgroundStructural Learning and Integrative Decomposition of Multi-View Data
Gaynanova, I., & Li, G. (2019) · Biometrics · doi:10.1111/biom.13108 · Cited by 78 · cited 2× · see citing works
“BIDIFAC + builds upon BIDIFAC (Park and Lock, 2019) and SLIDE (Gaynanova and Li, 2019), two extensions of the JIVE method (Lock et al., 2013) that yields matrix factorizations that convey a decomposition of data variability into variability shared across multiple ‘omics and variability primarily attributable to single…”
MethodMore effort — more results: recent advances in integrative ‘omics’ data analysis
Rajasundaram, D., & Selbig, J. (2016) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2015.12.010 · Cited by 67 · cited 2× · see citing works
“…focus on integration for specific ‘omics data types, such as single cell ‘omics (Ma et al., 2020) or specific application areas, such as plant biology (Rajasundaram and Selbig, 2016), microbial communities (Fondi and Liò, 2015; Franzosa et al., 2015), cancer (Buescher and Driggers, 2016), and…”
BackgroundConflations of probability distributions
Hill, T. P. (2011) · Transactions of the American Mathematical Society · doi:10.1090/s0002-9947-2011-05340-7 · Cited by 56 · cited 2× · see citing works
“Aggregation of these normal distributions is achieved through the process of statistical conflation (Hill, 2011), which involves taking the normalized product of the aggregated probability density functions.”
BackgroundAbela, L., Spiegel, R., Crowther, L. M., Klein, A., Steindl, K., Papuc, S. M., Joset, P., Zehavi, Y., Rauch, A., Plecko, B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176363 · Cited by 54 · cited 1× · see citing works
“Other studies that involve rare diseases, the collection of difficult-to-access tissue, or smaller grants that do not allow for large consortium samples are characterized by similarly low sample sizes (Sirrs et al., 2015; Abela et al., 2017).”
BackgroundMixed-effects statistical model for comparative LC–MS proteomics studies
Daly, D. S., Anderson, K. K., Panisko, E. A., Purvine, S. O., Fang, R., Monroe, M. E., & Baker, S. E. (2008) · Journal of Proteome Research · doi:10.1021/pr070441i · Cited by 50 · cited 1× · see citing works
“Peptides may be missing from one or more samples due to a variety of underlying mechanisms (Daly et al., 2008; Karpievitch et al., 2009), which can result in non-trivial amounts of potential observations being missing.”
BackgroundZhou, X., Chai, H., Zhao, H., Luo, C., & Yang, Y. (2020) · GigaScience · doi:10.1093/gigascience/giaa076 · Cited by 50 · see citing works
TOBMI: trans-omics block missing data imputation using a k-nearest neighbor weighted approach
Dong, X., Lin, L., Zhang, R., Zhao, Y., Christiani, D. C., Wei, Y., & Chen, F. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty796 · Cited by 49 · cited 1× · see citing works
“Trans-Omics Block Missing Data Imputation (TOBMI; Dong et al., 2018) proposes a similar method, but imputed values are generated based on a weighted average of neighbors, with closer neighbors having greater weights.”
MethodA Review of Imputation Strategies for Isobaric Labeling-Based Shotgun Proteomics
Bramer, L. M., Irvahn, J., Piehowski, P. D., Rodland, K. D., & Webb-Robertson, B.-J. M. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00123 · Cited by 47 · cited 2× · see citing works
“However, like mean imputation, imputed values from these approaches may distort feature distributions and lead to biased parameter and variability estimates (Lubin et al., 2004; Succop et al., 2004; Webb-Robertson et al., 2015; Lazar et al., 2016; Bramer et al., 2020).”
BackgroundMethodSelf-citationTermine, A., Fabrizio, C., Strafella, C., Caputo, V., Petrosini, L., Caltagirone, C., Giardina, E., & Cascella, R. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040280 · Cited by 45 · cited 1× · see citing works
“, 2021) and challenges in applying AI and ML techniques to multi-omics data (e.g., Kang et al., 2021; Termine et al., 2021).”
Abela, L., Simmons, L., Steindl, K., Schmitt, B., Mastrangelo, M., Joset, P., Papuc, M., Sticht, H., Baumer, A., Crowther, L. M., et al. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9876-y · Cited by 43 · cited 1× · see citing works
“For example, a study to identify biomarkers for Snyder Robinson syndrome, a rare neurological disorder, obtained data on 16 patients, only three of which presented with the disorder of interest (Abela et al., 2015).”
BackgroundPerspectives for better batch effect correction in mass-spectrometry-based proteomics
Phua, S.-X., Lim, K.-P., & Goh, W. W.-B. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.022 · Cited by 42 · cited 1× · see citing works
“For example, batch effects are common and often much more pronounced in mass spectrometry-based data (Mertens, 2016; Phua et al., 2022; e.g., Han and Li, 2020), even when the same physical instrument is used and the same data type is being generated.”
BackgroundMatsuda, F., Tsugawa, H., & Fukusaki, E. (2013) · Analytical Chemistry · doi:10.1021/ac401564v · Cited by 41 · cited 1× · see citing works
“In untargeted metabolomics and lipidomics false discovery rates are difficult to compute and largely not accurate (Stein, 1994; Jeong et al., 2011; Matsuda et al., 2013; Kim and Zhang, 2014).”
BackgroundSamaraweera, M. A., Hall, L. M., Hill, D. W., & Grant, D. F. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03118 · Cited by 41 · cited 1× · see citing works
“For small molecule measurements, such as metabolomics, manual verification of metabolites following identification scoring is required for shotgun metabolomics, as scoring methods are much less mature than for other ‘omics data types (Stein and Scott, 1994; Samaraweera et al., 2018).”
MethodBayesian Proteoform Modeling Improves Protein Quantification of Global Proteomic Measurements
Webb‐Robertson, B., Matzke, M. M., Datta, S., Payne, S., Kang, J., Bramer, L., Nicora, C., Shukla, A. K., Metz, T., Rodland, K., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030932 · Cited by 39 · cited 1× · see citing works
“, 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al., 2011; Webb-Robertson et al., 2014).”
BackgroundSelf-citationIntegration of artificial intelligence and multi-omics in kidney diseases
Zhou, S., Zhong, X., & Duan, L. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.01.037 · Cited by 35 · cited 3× · see citing works
“…metabolic engineering ( Helmy et al., 2020), precision medicine (Hamamoto et al., 2019), amongst others (e.g., Mann et al., 2021; Lin et al., 2022; Zhou et al., 2022) and a majority focused on cancer research (e.g., Wang and Gu, 2016; Biswas and Chakrabarti, 2020; Nicora et al., 2020; Cai et al.,…”
BackgroundInfluentialBayesian integrative model for multi-omics data with missingness
Fang, Z., Ma, T., Tang, G., Zhu, L., Yan, Q., Wang, T., Celedón, J. C., Chen, W., & Tseng, G. C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty775 · Cited by 34 · cited 3× · see citing works
“When an assumption of MCAR or MAR is used, the missingness is said to be ignorable and methods designed to handle missing values are applied to both cases (Gelman and Hill, 2006; Fang et al., 2018; Wei et al., 2018).”
BackgroundMethodAdvanced bioinformatics methods for practical applications in proteomics
Goh, W. W. B., & Wong, L. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx128 · Cited by 33 · cited 1× · see citing works
“…isolation and solubilization, sequence ambiguity, and a lack of standards in statistical thresholds and algorithms result in inconsistent detection of large proportions of protein products that are detected, thus limiting the reproducibility of data collection and analysis (Goh and Wong, 2017).”
BackgroundForshed, J., Johansson, H. J., Pernemalm, M., Branca, R. M. M., Sandberg, A., & Lehtiö, J. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010264 · Cited by 32 · cited 1× · see citing works
“, 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al., 2011; Webb-Robertson et al., 2014).”
BackgroundMulti-view clustering for multi-omics data using unified embedding
Mitra, S., Saha, S., & Hasanuzzaman, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70229-1 · Cited by 32 · see citing works
Mertens, B. J. A. (2017) · Statistical Analysis of Proteomics, Metabolomics, and Lipidomics Data Using Mass Spectrometry · doi:10.1007/978-3-319-45809-0_1 · Cited by 30 · cited 2× · see citing works
“effects are common and often much more pronounced in mass spectrometry-based data (Mertens, 2016; Phua et al., 2022; e.g., Han and Li, 2020), even when the same physical instrument is”
BackgroundLin, B., Ma, Y., & Wu, S. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0079 · Cited by 30 · cited 1× · see citing works
“, 2019), amongst others (e.g., Mann et al., 2021; Lin et al., 2022; Zhou et al., 2022) and a majority focused on cancer research (e.”
BackgroundHowey, R. A. J., Clark, A. D., Naamane, N., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009811 · Cited by 29 · see citing works
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms
Sirrs, S., van Karnebeek, C. D., Peng, X., Shyr, C., Tarailo-Graovac, M., Mandal, R., Testa, D., Dubin, D., Carbonetti, G., Glynn, S. E., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0248-3 · Cited by 28 · cited 1× · see citing works
“Other studies that involve rare diseases, the collection of difficult-to-access tissue, or smaller grants that do not allow for large consortium samples are characterized by similarly low sample sizes (Sirrs et al., 2015; Abela et al., 2017).”
BackgroundJeong, J., Shi, X., Zhang, X., Kim, S., & Shen, C. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-392 · Cited by 27 · cited 1× · see citing works
“In untargeted metabolomics and lipidomics false discovery rates are difficult to compute and largely not accurate (Stein, 1994; Jeong et al., 2011; Matsuda et al., 2013; Kim and Zhang, 2014).”
MethodA network embedding based method for partial multi-omics integration in cancer subtyping
Xu, H., Gao, L., Huang, M., & Duan, R. (2020) · Methods · doi:10.1016/j.ymeth.2020.08.001 · Cited by 27 · cited 1× · see citing works
“A more recent approach, Multiple Similarity Network Embedding (MSNE; Xu et al., 2021) modifies NEMO’s original framework to overcome limitations in the patterns of missing data that can be accommodated.”
MethodMONET: Multi-omic module discovery by omic selection
Rappoport, N., Safra, R., & Shamir, R. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008182 · Cited by 26 · cited 2× · see citing works
“Multi Omics clustering by Non-Exhaustive Types (MONET; Rappoport et al., 2020) is a clustering algorithm that defines “modules”, which are clusters formed based on subsets of different data views.”
MethodMerging Multiple Omics Datasets In Silico: Statistical Analyses and Data Interpretation
Arakawa, K., & Tomita, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-299-5_23 · Cited by 25 · cited 1× · see citing works
“…of these review articles have focused specifically on the availability of software tools and discussions of preprocessing considerations (e.g., Arakawa and Tomita, 2013; Misra et al., 2019), or on providing perspective on challenges in multi-omics integration (e.g., Gomez-Cabrero et al.,…”
BackgroundIntegrative factorization of bidimensionally linked matrices
Park, J. Y., & Lock, E. F. (2019) · Biometrics · doi:10.1111/biom.13141 · Cited by 23 · cited 10× · see citing works
“Traditional multi-omics considers the integration of several different ‘omics for the same set of samples, whereas the integration considered by BIDIFAC + involves combining different ‘omics and different sample sets.”
MethodInfluentialDeepMF: deciphering the latent patterns in omics profiles with a deep learning method
Chen, L., Xu, J., & Li, S. C. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3291-6 · Cited by 23 · cited 1× · see citing works
“DeepMF (Chen et al., 2019) casts traditional matrix factorization within a deep learning framework to map concatenated multiomics data to a lower-dimensional latent space.”
TiMEG: an integrative statistical method for partially missing multi-omics data
Das, S., & Mukhopadhyay, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-03034-z · Cited by 21 · cited 1× · see citing works
“Introduced by Das and Mukhopadhyay (2021), TiMEG (Tool for integrating Methylation, gene Expression and Genotype) is a supervised learning approach for the identification of disease-associated biomarkers in case-control multi-omics studies.”
BackgroundJoint association and classification analysis of multi‐view data
Zhang, Y., & Gaynanova, I. (2021) · Biometrics · doi:10.1111/biom.13536 · Cited by 20 · cited 1× · see citing works
“Joint association and classification analysis (JACA; Zhang and Gaynanova, 2021) is a semi-supervised approach that enables quantification of inter-omic associations with respect to known classifications or data subtypes.”
Bidimensional linked matrix factorization for pan-omics pan-cancer analysis
Lock, E. F., Park, J. Y., & Hoadley, K. A. (2022) · The Annals of Applied Statistics · doi:10.1214/21-aoas1495 · Cited by 19 · cited 1× · see citing works
“Unique from most other approaches described in this review, BIDIFAC + (Lock et al., 2022) is a matrix factorization approach for bi-dimensionally linked matrices.”
MethodLiang, K. (2013) · Elsevier eBooks · doi:10.1533/9781908818232.49 · Cited by 19 · see citing works
Detecting molecular subtypes from multi-omics datasets using SUMO
Sienkiewicz, K., Chen, J., Chatrath, A., Lawson, J. T., Sheffield, N. C., Zhang, L., & Ratan, A. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100152 · Cited by 18 · cited 5× · see citing works
“As well, the range of adjusted rand index values (the performance metric used) was typically observed to be narrower for SUMO, suggesting less variability in expected performance.”
BackgroundInfluentialA general framework for integrative analysis of incomplete multiomics data
Lin, D., Zeng, D., & Couper, D. (2020) · Genetic Epidemiology · doi:10.1002/gepi.22328 · Cited by 16 · cited 2× · see citing works
“Emphasizing analyses more consistent with a causal framework, iMODA (Lin et al., 2020) proposes a hierarchical regression framework for quantifying (i) the effects of genotypes on quantitative ‘omics, (ii) the effects of quantitative ‘omics on response phenotypes of interest, and (iii) the direct and indirect effects…”
MethodDiscovery of false identification using similarity difference in GC–MS‐based metabolomics
Kim, S., & Zhang, X. (2014) · Journal of Chemometrics · doi:10.1002/cem.2665 · Cited by 15 · cited 1× · see citing works
“In untargeted metabolomics and lipidomics false discovery rates are difficult to compute and largely not accurate (Stein, 1994; Jeong et al., 2011; Matsuda et al., 2013; Kim and Zhang, 2014).”
BackgroundscMoC: single-cell multi-omics clustering
Eltager, M., Abdelaal, T., Mahfouz, A. E., & Reinders, M. J. T. (2022) · Bioinformatics Advances · doi:10.1093/bioadv/vbac011 · Cited by 13 · see citing works
Ni, Z., Zheng, X., Zheng, X. K., & Zou, X. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.3025804 · Cited by 11 · cited 1× · see citing works
“Last, Ni et al. (2022) introduce scLRTD, an imputation approach based on approximating a third-order tensor representation of the multi-omics dataset with a low-rank approximation.”
MethodLee, D., & Kim, S. (2021) · Korean Journal of Pediatrics · doi:10.3345/cep.2021.01438 · Cited by 10 · see citing works
Model-based joint visualization of multiple compositional omics datasets
Hawinkel, S., Bijnens, L., Cao, K.-A. L., & Thas, O. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa050 · Cited by 9 · cited 2× · see citing works
“, 2018), Compositional Omics ModelBased Integration (COMBI; Hawinkel et al., 2020) introduces model extensions better suited for modeling compositional and sequence count data.”
BackgroundCoupling Deep Imputation with Multitask Learning for Downstream Tasks on Genomics DataPreprint
Peacock, S., Jacob, E., & Burlutskiy, N. (2022) · arXiv (Cornell University) · doi:10.48550/arxiv.2204.13705 · Cited by 1 · see citing works
Flagged first, then by citations
11 of the 148 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Achille, 2017, Emergence of invariance and disentanglement in deep representations, J. Machine Learn. Res., 19, 1, 10.48550/arxiv.1706.01350 · DOI
- A variational information bottleneck approach to multi-omics data integration,15131521 LeeC. van der SchaarM. International Conference on Artificial Intelligence and Statistics2021
- Sindhwani, 2005, A co-regularization approach to semi-supervised learning with multiple views,
Cited by
Sorted by citations
Deep learning-based approaches for multi-omics data integration and analysis
Ballard, J. L., Wang, Z., Li, W., Shen, L., & Long, Q. (2024) · BioData Mining · doi:10.1186/s13040-024-00391-z · Cited by 287 · see citing works
“The former results in a reduced sample size while not allowing the full usage of all information contained in the dataset, and the samples with missing values may not be a random subset of the data [101].”
BackgroundBaião, A. R., Cai, Z., Poulos, R. C., Robinson, P. J., Reddel, R. R., Zhong, Q., Vinga, S., & Gonçalves, E. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf355 · Cited by 249 · see citing works
Cembrowska-Lech, D., Krzemińska, A., Miller, T. I., Nowakowska, A., Adamski, C., Radaczyńska, M., Mikiciuk, G., & Mikiciuk, M. (2023) · Biology · doi:10.3390/biology12101298 · Cited by 193 · see citing works
“Moreover, AI and machine learning techniques can be leveraged to analyze the large and complex datasets generated by these methods, revealing hidden patterns and predictive models of plant phenotypes [56–58].”
BackgroundRevolutionizing multi‐omics analysis with artificial intelligence and data processing
Yetgin, A. (2025) · Quantitative Biology · doi:10.1002/qub2.70002 · Cited by 152 · see citing works
“Due to the size and complexity of the data produced by various omics technologies, AI and data processing are essential elements in multi ‐ omics analysis [16].”
Acharya, D., & Mukhopadhyay, A. (2024) · Briefings in Functional Genomics · doi:10.1093/bfgp/elae013 · Cited by 131 · see citing works
Schouten, D., Nicoletti, G., Dille, B., Chia, C., Vendittelli, P., Schuurmans, M., Litjens, G., & Khalili, N. (2025) · Medical Image Analysis · doi:10.1016/j.media.2025.103621 · Cited by 108 · see citing works
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Yu, B., Shao, S., & Ma, W. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217350 · Cited by 112 · see citing works
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure
Ghazal, R., Wang, M., Liu, D., Tschumperlin, D. J., & Pereira, N. L. (2025) · Circulation Research · doi:10.1161/circresaha.124.325402 · Cited by 109 · see citing works
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective
Salvioli, S., Basile, M. S., Bencivenga, L., Carrino, S., Conte, M., Damanti, S., LORENZO, R. D., Fiorenzato, E., Gialluisi, A., Ingannato, A., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102044 · Cited by 85 · see citing works
Multi-omics integration analysis: Tools and applications in environmental toxicology
Shi, C., Cheng, L., Yu, Y., Chen, S., Dai, Y., Yang, J., Zhang, H., Chen, J., & Geng, N. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124675 · Cited by 82 · see citing works
Sen, P., & Orešič, M. (2023) · Metabolites · doi:10.3390/metabo13070855 · Cited by 74 · see citing works
Amin, A., Zaman, W., & Park, S. (2025) · Genes · doi:10.3390/genes16070809 · Cited by 82 · see citing works
Artificial intelligence and multi-omics in pharmacogenomics: a new era of precision medicine
Zack, M., Stupichev, D. N., Moore, A. J., Slobodchikov, I. D., Sokolov, D. G., Trifonov, I. F., & Gobbs, A. (2025) · Mayo Clinic Proceedings: Digital Health · doi:10.1016/j.mcpdig.2025.100246 · Cited by 70 · see citing works
“23,24 It recognizes that genotype alone does not capture dynamic processes such as gene regulation, post-translational modifications, or shifts in metabolism.”
Ganie, S. A., McMulkin, N., & Devoto, A. (2024) · Plant Cell & Environment · doi:10.1111/pce.14855 · Cited by 71 · see citing works
Multi-omics data integration and analysis pipeline for precision medicine: Systematic review
Abdelaziz, E. H., Ismail, R. M., Mabrouk, M. S., & Amin, E. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108254 · Cited by 62 · see citing works
Machine learning for the advancement of genome-scale metabolic modeling
Kundu, P., Beura, S., Mondal, S., Das, A. K., & Ghosh, A. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108400 · Cited by 52 · see citing works
Dave, J. K., Jagana, V., Janoštiak, R., & Bisserier, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04339-5 · Cited by 50 · see citing works
“However, with recent artificial intelligence developments and publicly accessible datasets, multiomics data analysis has greatly improved, assuming access to all observed data following sample testing [131, 135].”
BackgroundIntegrative Multi-Omics and Artificial Intelligence: A New Paradigm for Systems Biology
Kant, S., Deepika, & Roy, S. (2025) · OMICS A Journal of Integrative Biology · doi:10.1177/15578100251392371 · Cited by 61 · see citing works
“Methods used for imputation span low-level techniques such as mean or median imputation, to hot-deck, traditional ML, to advanced deep learning (DL) models suited for high-dimensional omics data (Flores et al., 2023; Voillet et al., 2016).”
A machine learning and deep learning-based integrated multi-omics technique for leukemia prediction
Abbasi, E. Y., Deng, Z., Arain, Q. A., Khan, A., Shaikh, A., Reshan, M. S. A., Sulaiman, A. A., & Alshahrani, H. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25369 · Cited by 49 · see citing works
“Only features with more than 20 % and less than 50 % of the data missing score were included [61].”
BackgroundBernardini, M., Doinychko, A., Romeo, L., Frontoni, E., & Amini, M.-R. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107188 · Cited by 42 · see citing works
PathIntegrate: Multivariate modelling approaches for pathway-based multi-omics data integration
Wieder, C., Cooke, J., Frainay, C., Poupin, N., Bowler, R. P., Jourdan, F., Kechris, K. J., Lai, R., & Ebbels, T. M. D. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011814 · Cited by 43 · see citing works
“However, further work is required to develop multi-omics integration methods that can handle samples with one or more omics missing [70] (missing not at random [68]).”
Machine learning for extracellular vesicles enables diagnostic and therapeutic nanobiotechnology
Tiwari, A. K., Widodo, Krisnawati, D. I., Tzou, K.-Y., & Kuo, T. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03952-4 · Cited by 52 · see citing works
Yoon, J. H., Lee, H., Kwon, D., Lee, D., Lee, S., Cho, E., Kim, J., & Kim, D. (2024) · Brain Communications · doi:10.1093/braincomms/fcae265 · Cited by 39 · see citing works
“79,80 As many trials using genome-wide association studies and multi-omics data to detect Alzheimer’s disease risk genes and drug targets are not successful, attempts including drug repurposing have been made to apply statistics and machine/deep learning to multi-omics to gain new insights.”
BackgroundMultimodal Integration in Health Care: Development With Applications in Disease Management
Hao, Y., Cheng, C., Li, J., Li, H., Di, X., Zeng, X., Jin, S., Han, X., Liu, C., Wang, Q., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/76557 · Cited by 43 · see citing works
“Inconsistent data collection practices, missing entries, and recording errors can compromise model reliability, necessitating robust standardization protocols [84].”
Chen, Z., Liu, A., Zhang, X., Cao, X., Ding, Z., Sha, Q., Shen, H., Deng, H., & Zhou, W. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108058 · Cited by 33 · see citing works
Integrating multi-omics and machine learning for disease resistance prediction in legumes
Mohamedikbal, S., Al-Mamun, H. A., Bestry, M., Batley, J., & Edwards, D. (2025) · Theoretical and Applied Genetics · doi:10.1007/s00122-025-04948-2 · Cited by 31 · see citing works
Ouhmouk, M., Baichoo, S., & Abık, M. (2025) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2025.101679 · Cited by 29 · see citing works
Elrashedy, A., Mousa, W. S., Nayel, M., Salama, A. A., Zaghawa, A. A., Elsify, A. M., & Hasan, M. E. (2025) · Virology Journal · doi:10.1186/s12985-025-02640-x · Cited by 25 · see citing works
Liu, Z., & Park, T. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1488683 · Cited by 25 · see citing works
Computational Methods for Data Integration and Imputation of Missing Values in Omics Datasets
Schumann, Y., Gocke, A., & Neumann, J. E. (2024) · PROTEOMICS · doi:10.1002/pmic.202400100 · Cited by 28 · see citing works
“In particular, this work focuses on the integration of multiple cohorts from the same omic -type and the reader is referred to the reviews in [1–3] for an overview of multi-omic data integration and to [4] for an integrated consideration of multi-omics with missing values.”
Multi-Omics Integration in Nephrology: Advances, Challenges, and Future Directions
Saliba, A., Du, Y., Feng, T., & Garmire, L. X. (2024) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2025.151584 · Cited by 30 · see citing works
“Readers are referred to more details in the review of Flores et al. 28”
Computational Metagenomics: State of the Art
Pita-Galeana, M. A., Ruhle, M., López-Vázquez, L., de Anda‐Jáuregui, G., & Lemus, E. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189206 · Cited by 26 · see citing works
“ML and AI methods such as k-nearest neighbors (KNN) imputation, random forest imputation, and expectation-maximization algorithms better capture relationships among features [160].”
InfluentialMoving towards genome-wide data integration for patient stratification with Integrate Any Omics
Ma, S., Zeng, A. G. X., Haibe‐Kains, B., Goldenberg, A., Dick, J. E., & Wang, B. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-024-00942-3 · Cited by 23 · see citing works
“Advanced integrative methods to address the missing data issue can be classified into two categories: joint imputation or optimization masking 22 .”
Ameliorating microalgal OMEGA production using omics platforms
Mariam, I., Bettiga, M., Rova, U., Christakopoulos, P., Μάτσακας, Λ., & Patel, A. (2024) · Trends in Plant Science · doi:10.1016/j.tplants.2024.01.002 · Cited by 24 · see citing works
Human‐based new approach methodologies to accelerate advances in nutrition research
Cassotta, M., Cianciosi, D., Elexpuru-Zabaleta, M., Elío, I., Cano, S. S., Giampieri, F., & Battino, M. A. (2024) · Food Frontiers · doi:10.1002/fft2.369 · Cited by 23 · see citing works
Evaluation of normalization strategies for mass spectrometry-based multi-omics datasets
Tseng, C. Y., Salguero, J. A., Breidenbach, J. D., Solomon, E. A., Sanders, C. K., Harvey, T., Thornhill, M. G., Palmisano, S. J., Sasiene, Z. J., Blackwell, B. R., et al. (2025) · Metabolomics · doi:10.1007/s11306-025-02297-1 · Cited by 25 · see citing works
“These technical factors affect omics feature identification, quantification, and missing value gen - eration, varying by omics type and complicate the selection of normalization methods (Brombacher et al., 2025; Flores et al., 2023; Kong et al., 2022).”
The impact of artificial intelligence on biomarker discovery
Javaid, H., Petrescu, C. C., Schmunk, L. J., Monahan, J., O’Reilly, P. G., Garg, M., McGirr, L., Khasawneh, M., Lail, M. A., Ganta, D., et al. (2025) · Emerging Topics in Life Sciences · doi:10.1042/etls20243003 · Cited by 31 · see citing works
Omics big data for crop improvement: Opportunities and challenges
Vasupalli, N., Bhat, J. A., Jain, P., Sri, T., Islam, M. A., Shivaraj, S. M., Singh, S. K., Deshmukh, R., Sonah, H., & Lin, X. (2024) · The Crop Journal · doi:10.1016/j.cj.2024.10.007 · Cited by 21 · see citing works
MARIA: A multimodal transformer model for incomplete healthcare data
Caruso, C. M., Soda, P., & Guarrasi, V. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110843 · Cited by 23 · see citing works
“Various techniques are available for fusing latent representations from different modalities, and we recommend readers refer to the review [1] for an in-depth exploration of these methods. imputer, which has demonstrated effectiveness in handling missing values in tabular data [5, 6, 7].”
The Immune System and Cellular Senescence: A Complex Interplay in Aging and Disease
Ayoub, M., Jaoude, C. A., Ayoub, M., Hamadé, A., & Rima, M. (2025) · Immunology · doi:10.1111/imm.70036 · Cited by 22 · see citing works
“More accurate and customised immunosenescence assessment systems are being created as a result of the rapid advancement of multi-omics techniques (genomics, transcrip-tomics, proteomics and metabolomics) discussed in Section 6.1, and the incorporation of artificial intelligence [229, 231–232].”
InfluentialRadío, S., Marsico, M. D., Bersani, C., Malinverni, R., Casacuberta, J., Corpetti, C., Cigliano, R. A., & Sanseverino, W. (2024) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2024.en-9086 · Cited by 16 · see citing works
Hsieh, Y. E., Tandon, K., Verbruggen, H., et al. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf109 · Cited by 15 · see citing works
“However, metatranscriptomic data are often sparse, with relatively few genes showing considerable expression,which can be influenced by taxon and/or gene–family abundance [53–55].”
Olawade, D. B., Kade, A., Egbon, E., Usman, S. O., Fapohunda, O., Ijiwade, J. O., & Ogbonna, C. E. (2025) · Molecular Genetics and Genomics · doi:10.1007/s00438-025-02314-x · Cited by 18 · see citing works
“Furthermore, integration must include varying sizes and measurement units across distinct omics layers (Flores et al. 2023 ).”
Leveraging Artificial Intelligence for Synergies in Drug Discovery: From Computers to Clinics
Arora, P., Behera, M., Saraf, S. A., & Shukla, R. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128308066240529121148 · Cited by 14 · see citing works
Key Proteomics Tools for Fundamental and Applied Microalgal Research
Plouviez, M., & Dubreucq, E. (2024) · Proteomes · doi:10.3390/proteomes12020013 · Cited by 9 · see citing works
“In addition, especially for high-throughput techniques, huge datasets are being generated and, therefore, require the use of bioinformatics tools and pipelines to acquire and analyze data [24,31,88–90].”
BackgroundResultInfluentialFeng, J., Liu, Y., Li, K., & Wu, Y. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125332 · Cited by 12 · see citing works
Zhan, A. (2025) · Biological Diversity · doi:10.1002/bod2.70015 · Cited by 12 · see citing works
Network-based analyses of multiomics data in biomedicine
Kumar, R., Romano, J. D., & Ritchie, M. D. (2025) · BioData Mining · doi:10.1186/s13040-025-00452-x · Cited by 15 · see citing works
“The most prominent in this review were the curse of dimensionality (having far more features than samples in many cases) [68, 69] and the issue of addressing noise and sparsity in some datasets [15, 70].”
Torres-Narvaez, E. S., González, D., Artunduaga-Alvarado, J. A., & Ortega‐Recalde, O. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1584178 · Cited by 14 · see citing works
Emerging Trends in Systems Biology: Multi-Omics Integration and Beyond
Wang, N., Zhang, G., & Li, M. (2024) · Computational Molecular Biology · doi:10.5376/cmb.2024.14.0024 · Cited by 10 · see citing works
Polizel, G. H. G., Fanalli, S. L., Diniz, W. J. S., Cesar, A. S. M., Cônsolo, N. R. B., Fukumasu, H., Cánovas, Á., Fernandes, A. C., Prati, B. C. T., Furlan, É., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78965-4 · Cited by 11 · see citing works
“Following the protocol outlined for proteome and metabolome datasets 23 , we chose a soft threshold of 15, resulting in a mean connectivity of 8.40.”
InfluentialUnlocking biological complexity: the role of machine learning in integrative multi-omics
Kumar, R., Ruhel, R., & van Wijnen, A. J. (2024) · Academia Biology · doi:10.20935/acadbiol7428 · Cited by 12 · see citing works
“The synergy between ML and multi-omics holds immense promise for advancing our understanding of biology and improving clinical outcomes [6].”
Navigating multi-omic integration methods for human microbiome research
Muller, E., Bamberger, T., & Borenstein, E. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02328-0 · Cited by 11 · see citing works
“…integration where each omic is first modelled and then models’ outcomes are combined) 42 , (4) the characteristics of the omic data that can be integrated (for example, supported number of omics, data types, distributions and so on) and finally, (5) the algorithmic scale and distribution 35–37 .”
Vo, T. H., & Le, N. Q. K. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag227 · Cited by 11 · see citing works
“These modality-specific differences are widely documented in multi-omics integration studies as major challenges for data harmonization and fusion, particularly due to heterogeneity across data types, high dimensionality, and incomplete modality coverage [40–42].”
InfluentialComputational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study
Ortega-Vallbona, R., Palomino‐Schätzlein, M., Tolosa, L., Benfenati, E., Ecker, G. F., Gozalbes, R., & Serrano‐Candelas, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011154 · Cited by 10 · see citing works
“ML models require larger sample sizes for a correct fitting and can suffer from overfitting challenges if dimensionality problems arise from having too many omics variables associated with insufficient samples [117,188,191].”
BackgroundMethodInfluentialFehr, K. B., Mertens, A., Shu, C.-H., Dailey-Chwalibóg, T., Shenhav, L., Allen, L. H., Beggs, M. R., Bode, L., Chooniedass, R., DeBoer, M. D., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1548739 · Cited by 10 · see citing works
Wettinger, S. B., Karađuzović-Hadžiabdić, K., Attard, R., Farrugia, R. C., Wolford, B. N., Chierici, M., Jurman, G., Alexiou, P., Peñalvo, J. L., Costa, R. S., et al. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf526 · Cited by 9 · see citing works
“Many algorithms require complete data matrices and thus various imputation techniques for handling missing data in bioinformatics have been explored in the context of multiomic imputation [98–100], including deep learning/AI for the integrative imputation of multiomic datasets [98].”
Gliozzo, J., Gomez, M. A. S., Bonometti, A., Patak, A., Casiraghi, E., & Valentini, G. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf150 · Cited by 8 · see citing works
“…fusion methods are effective for disease subtype identification, biomarker discovery, and prognosis prediction, most cannot handle incomplete, or “partial”, datasets (Gliozzo et al. 2022, Flores et al. 2023) where one or more data sources are entirely missing for some patients (Supplementary Fig.”
Ramesh, D., Manickavel, P., Ghosh, S., & Bhat, M. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.102611 · Cited by 9 · see citing works
Alwahaibi, N., & Alwahaibi, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1678753 · Cited by 8 · see citing works
“Reproducibility is hindered by variable sample preservation, sequencing depth, and analytical pipelines (186, 187).”
Sen, C. K., & DeMazumder, D. (2025) · Advances in wound care · doi:10.1177/21621918251380217 · Cited by 11 · see citing works
Integrating Machine Learning and Multi-Omics to Explore Neutrophil Heterogeneity
Lin, Z., Yang, T., Chen, D., Zhang, P., Luo, J., Chen, S., Gu, S., Shen, Y., Tang, T.-X., Chang, T., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13092171 · Cited by 7 · see citing works
“Transparency and interpretability of AI and ML models are critical to promoting trust and accountability, as algorithms do not fully mimic real biological processes, which can erode clinician confidence and hinder clinical adoption [116].”
InfluentialSynOmics: integrating multi-omics data through feature interaction networks
Alif, M. N., & Zhang, W. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf595 · Cited by 10 · see citing works
Thoniyot, S., & Balakrishnan, V. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108772 · Cited by 9 · see citing works
Mtoor, S., Rashidian, N., Messaoudi, N., Grasso, V., Noël, F., Steindler, M., Jaradat, D., Frigerio, I. M., Butturini, G., Croner, R., et al. (2026) · Bioengineering · doi:10.3390/bioengineering13010117 · Cited by 7 · see citing works
“However, practical barriers remain substantial: multi-omics datasets differ in signal-to-noise ratios, suffer from missingness and partial observation, and often require imputation strategies that can introduce dependencies and bias if not carefully handled [72–74].”
EATRIS-Plus Multi-omics working group and Stakeholders, Alonso-Andrés, P., Baldazzi, D., Chen, Q., Conde, E., Crespo-Toro, L., Donner, K. M., Džubák, P., Ekberg, S., García‐Bermejo, L., et al. (2025) · Phenomics · doi:10.1007/s43657-024-00170-0 · Cited by 8 · see citing works
“While some integrative multi-omics methods can handle missing observations in some data modalities (Argelaguet et al. 2020; Cuklina et al. 2021), many methods require complete observations (Flores et al. 2023).”
How did we get there? AI applications to biological networks and sequences
Anteghini, M., Gualdi, F., & Oliva, B. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110064 · Cited by 9 · see citing works
Machine Learning for Predicting Stroke Risk Stratification Using Multiomics Data: Systematic Review
Yoo, H. Y., Shin, H., Kim, E. E., & Son, Y.-J. (2026) · Journal of Medical Internet Research · doi:10.2196/85654 · Cited by 7 · see citing works
“Additionally, the definition of the analysis unit—for example, gene-level expression, CpG probe values, or LC-MS features—determined the imputation burden, multiplicity, and scope of feasible feature selection methods, thereby influencing both model performance and reproducibility [55,57,58].”
Multi-omics Quality Assessment in Personalized Medicine through EATRISPreprint
EATRIS Plus Multi-omics working group and stakeholders (in alphabetical order by last name), Alonso-Andrés, P., Baldazzi, D., Chen, Q., Conde, E., Crespo-Toro, L., Donner, K. M., Džubák, P., Ekberg, S., García‐Bermejo, L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.25.563912 · Cited by 6 · see citing works
Yang, T., & Li, W. V. (2025) · BMC Bioinformatics · doi:10.1186/s12859-025-06227-9 · Cited by 5 · see citing works
“Integrative methods for multi-modal data are typically categorized into three main approaches: early, middle, and late integration [7].”
Mukhopadhyay, S., Ulaganathan, N., Dumpuri, P., & Aich, P. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4690-8_2 · Cited by 6 · see citing works
Genome-scale metabolic modelling in antimicrobial pharmacology: Present and future
Tao, J., Lin, Y.-W., Zhong, L., Zhu, Y., Yao, X., Aichem, M., Schreiber, F., Zhao, J., & Li, J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115672 · Cited by 5 · see citing works
Zhong, H., Chi, S.-X., Magaña, A. A., Fordwour, O., & Foster, L. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00294 · Cited by 2 · see citing works
Mass Spectrometry Proteomics: A Key to Faster Drug Discovery
Tagliazucchi, L., & Costi, M. P. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01986 · Cited by 7 · see citing works
Liu, X., Bin, C., Gao, Q., Li, M., Xue, L., Zhou, Z., Liu, M., Ji, X., & Wei, S. (2026) · Biomarker Research · doi:10.1186/s40364-026-00914-2 · Cited by 7 · see citing works
“Strategy selection should, accordingly, prioritise approaches that tolerate missing blocks and avoid complete-case dependence [70, 454].”
A journey from omics to clinicomics in solid cancers: Success stories and challenges
Mehrotra, S., Sharma, S., & Pandey, R. K. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.11.008 · Cited by 5 · see citing works
Han, S., Yu, S., Shi, M., Harada, M., Ge, J., Lin, J.-S., Prehn, C. P., Petrera, A., Li, Y., Sam, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58314-3 · Cited by 5 · see citing works
“The incompletenessof these datasets hindersmulti-omics integration 9 and investigations into predisposing factors (such as age and genetics), enabling factors (such as healthcare service and physical activity), and Fig.”
Zhou, W., Chen, Z., Liu, A., Zhang, X., Cao, X., Ding, Z., Sha, Q., Shen, H., & Deng, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2768563/v1 · Cited by 5 · see citing works
Multi-omics and Artificial Intelligence technology for elucidating disease pathophysiology.Preprint
Jin, J., & Kim, J. J. (2024) · Preprints.org · doi:10.20944/preprints202408.0350.v1 · Cited by 4 · see citing works
Genetic and epigenetic drivers of neurodegenerative disorders
Roy, K., Syed, M., Narad, P., & Sengupta, A. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.002 · Cited by 5 · see citing works
Okafor, U. C., Alghamdi, S. M., Anguilano, L., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1742848 · Cited by 4 · see citing works
“…from a lack of diversity in the soil-dwelling microbial taxa primarily due to the focus on model organisms that have been previously studied, and as a result, the microbial taxa that are present in soil that is tropical, arid, or chronically contaminated (Wang et al., 2023; Flores et al., 2023).”
A review of multi-omics integration techniques across five machine learning method families
Olowolayemo, A., Souag, A., Sirlantzis, K., Turner, S., & Wilson, C. M. (2026) · Bioinformatics Advances · doi:10.1093/bioadv/vbag108 · Cited by 4 · see citing works
“2022, Flores et al .”
InfluentialArtificial Intelligence-Based Methods and Omics for Mental Illness Diagnosis: A Review
de Oliveira, G. S., Rodrigues, F. H. D. S., Pontes, J. G. D. M., & Tasić, L. (2025) · Bioengineering · doi:10.3390/bioengineering12101039 · Cited by 4 · see citing works
“Beyond statistical analysis and model training, AI can also enhance different stages of omics workflows and facilitate multi-omics data integration [20].”
Multi-Omics Approaches for Reproductive Health Data
Menon, S. V., Joshi, G., Khadka, S., Joshi, P., Narayan, Y., Mahalingam, N. K., & Bhandari, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7451-7_4 · Cited by 4 · see citing works
Simplicity within biological complexity
Pržulj, N., & Malod‐Dognin, N. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbae164 · Cited by 4 · see citing works
“…include: lack of robustness to noise and overfitting due to scarcity of labelled data, interpretability, and real networks usually being “multiplex” [201], i.e. having incomplete multi-view representations from different relations (some works recently attempting to address it [160, 161, 162, 202]).”
BackgroundChoudhury, P., Dasgupta, S., Bhattacharyya, P., et al. (2024) · Molecular Omics · doi:10.1039/d3mo00266g · Cited by 3 · see citing works
Deep fusion of incomplete multi-omic data for molecular mechanism of Alzheimer’s disease
Xie, L., Raj, Y., Tong, M., Nho, K. T., Salama, P., Saykin, A. J., Fang, S., & Yan, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-14636-2 · Cited by 3 · see citing works
Huang, W.-J., Lin, R., Zeng, X.-Y., Wang, H., & Yan, J.-C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1665688 · Cited by 3 · see citing works
Bioinformatics Strategies in Breast Cancer Research
Veneziano, M., Savini, I., Cortellesi, E., Gasperi, V., Gambacurta, A., & Catani, M. V. (2025) · Biomolecules · doi:10.3390/biom15101409 · Cited by 3 · see citing works
“…approaches (such as identifying relationships between biomarkers through models that better integrate well-known biological structures) and manages challenges like noisy data, missing information from some omics technologies, and reducing reliance on manual feature engineering [133,134].”
Mu, N., Yang, H., & Chen, Z. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109179 · Cited by 4 · see citing works
Zivalj, D., Schleicher, L. M. S., Kršek, A., Diamee, H. J. F., Raljević, D., & Batičić, L. (2026) · Life · doi:10.3390/life16030400 · Cited by 4 · see citing works
Trends in the Application of Multiomics Based on Machine Learning in the Development of Probiotics
Chen, Y., Xing, Z., Sheng, J., Liu, X., Ding, W., & Chen, X. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c15387 · Cited by 5 · see citing works
Mapping the path to clinical implementation of multi-omics
Ismail, S. I., Saad, C., Elrayess, M. A., Khleifat, A. A., Hendi, N. N., Al-Sarraj, Y. A., Badji, R. M., & Al‐Muftah, W. (2026) · Nature Genetics · doi:10.1038/s41588-026-02663-2 · Cited by 5 · see citing works
“AI approaches, including deep learning and advanced imputation frameworks, are emerging as solutions for reconstructing missing information, integrating partially observed datasets and improving model robustness 57 .”
Decoding cell fate: integrated experimental and computational analysis at the single-cell level
Zhou, Y., Hou, S., Miao, X., Zhang, G., Li, Z., Zhang, D., Lin, Y., & Lin, Y. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf603 · Cited by 4 · see citing works
“Building such context-aware, benchmarked frameworks will be essential for integrative analyses that remove technical artifacts while preserving biologically meaningful variation (Flores et al. 2023).”
ProteoArk: A One-Pot Proteomics Data Analysis and Visualization Tool for Biologists
Nisar, M., Soman, S. P., Sreelan, S., John, L., Pinto, S. M., Kandasamy, R. K., Subbannayya, Y., Prasad, T. S. K., Kanekar, S., Raju, R., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00556 · Cited by 3 · see citing works
Penalized likelihood optimization for censored missing value imputation in proteomics
Etourneau, L., Fancello, L., Wieczorek, S., Varoquaux, N., & Bürger, T. (2024) · Biostatistics · doi:10.1093/biostatistics/kxaf006 · Cited by 4 · see citing works
Liquid-based cytology in the era of multi-omics and artificial intelligence integration
Ahuja, S., & Zaheer, S. (2025) · CytoJournal · doi:10.25259/cytojournal_89_2025 · Cited by 2 · see citing works
“[9] In addition, the pre-analytical phase – including sample fixation, storage, and processing – can significantly influence molecular test performance.”
Li, D., Liao, K., Yan, B., Huang, J., Zhang, J., Chen, Y., Zhu, J., Zhi, S., & Chen, P. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1622600 · Cited by 4 · see citing works
Jin, D., & Saitō, Y. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf698 · Cited by 2 · see citing works
“However, these datasets are often incomplete, with missing omics modalities in a substantial proportion of samples [8].”
Decoding disease and therapy through multiomics integration and systems analysis
Mathew, M. J., Mathew, J., Chacko, R. M., Bayry, J., & Zagury, J. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag311 · Cited by 5 · see citing works
“Despite advances, imputing missing values remains a challenge when the proportion of missing data is high and is varied across different omics datasets [ 82].”
- Authors
- Flores, J. E., Claborne, D. M., Weller, Z. D., Webb-Robertson, B.-J. M., Waters, K. M., & Bramer, L. M.
- Affiliations
- Pacific Northwest National Laboratory (US)
- Corresponding author
- Bramer, Lisa M.
- Venue
- Frontiers in Artificial Intelligence
- Publisher
- Frontiers Media SA
- Published
- 2023-02-09
- Volume
- 6
- Pages
- 1098308-1098308
- ISSN
- 2624-8212 (ISSN-L)
- PMC
- PMC9949722
- OpenAlex
- W4319759388
- Semantic Scholar
- d833d42089ae664847832f8c0ef7bd7f6c1e26b6
- Cited by
- 181
- References
- 148
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 38 · 2023: 11
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Artificial Intelligence (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- Pacific Northwest National Laboratory
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Keywords
- missing data, multi-omics integration, artificial intelligence, statistical learning, missing data imputation, data heterogeneity, biological systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review